Nuvve Holding (NVVE) 10-Q 13 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 06, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-40296
Entity Registrant Name	NUVVE HOLDING CORP.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-1617000
Entity Address, Address Line One	2488 Historic Decatur Road, Suite 200
Entity Address, City or Town	San Diego,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92106
City Area Code	(619)
Local Phone Number	456-5161
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		6,527,227
Amendment Flag	false
Entity Central Index Key	0001836875
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	NVVE
Security Exchange Name	NASDAQ
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants to Purchase Common Stock
Trading Symbol	NVVEW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 1,431,414	$ 1,534,660
Restricted cash	480,000	480,000
Accounts receivable, net	516,193	1,724,899
Inventories	6,044,136	5,889,453
Prepaid expenses	789,112	994,719
Deferred costs	1,394,824	1,667,602
Other current assets	633,565	751,412
Total current assets	11,289,244	13,042,745
Property and equipment, net	709,916	766,264
Intangible assets, net	1,132,484	1,202,203
Investment in equity securities	670,951	670,951
Investment in leases	106,916	112,255
Right-of-use operating lease assets	4,593,229	4,839,526
Financing receivables	0	288,872
Security deposit, long-term	24,285	27,690
Total assets	18,527,025	20,950,506
Current liabilities
Accounts payable	1,869,527	1,694,325
Accrued expenses	4,920,770	4,632,101
Deferred revenue	1,069,978	1,030,056
Operating lease liabilities - current	848,497	856,250
Other liabilities	7,170	105,141
Total current liabilities	8,715,942	8,317,873
Operating lease liabilities - noncurrent	4,413,069	4,646,383
Warrants liability	1,484,504	4,621
Derivative liability - non-controlling redeemable preferred shares	313,354	309,728
Other long-term liabilities	867,404	681,438
Total liabilities	15,794,273	13,960,043
Commitments and Contingencies
Mezzanine equity
Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2024 and December 31, 2023; aggregate liquidation preference of $3,901,709 and $3,750,201 at June 30, 2024 and December 31, 2023, respectively	4,516,561	4,193,629
Stockholders’ equity
Common stock, $0.0001 par value, 100,000,000 shares authorized; 6,527,227 and 1,246,589 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	6,403	5,927
Additional paid-in capital	162,146,327	155,615,962
Accumulated other comprehensive income	71,932	93,676
Accumulated deficit	(158,894,045)	(148,240,859)
Nuvve Holding Corp. Stockholders’ Equity	3,330,617	7,474,706
Non-controlling interests	(5,393,107)	(4,894,101)
Total stockholders’ (deficit) equity	(2,062,490)	2,580,605
Total Equity	2,732,752	6,990,463
Total Liabilities and Equity	18,527,025	20,950,506
Class D Incentive Units
Mezzanine equity
Class D Incentive units, zero par value, 1,000,000 units authorized; 50,000 units issued and outstanding at June 30, 2024 and December 31, 2023, respectively	278,681	216,229
Cumulative Preferred Stock
Stockholders’ equity
Preferred stock, $0.0001 par value, 1,000,000 shares authorized; zero shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Temporary equity, par value (in Dollars per share)	$ 0	$ 0
Temporary equity, shares authorized (in Shares)	1,000,000	1,000,000
Temporary equity, shares issued (in Shares)	3,138	3,138
Temporary equity, shares outstanding (in Shares)	3,138	3,138
Temporary equity, liquidation preference	$ 3,901,709	$ 3,750,201
Preferred stock par value (in Dollars per share)	$ 0.0001
Preferred stock, shares authorized (in Shares)	1,000,000
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in Shares)	100,000,000	100,000,000
Common stock, shares issued (in Shares)	6,527,227	1,246,589
Common stock, shares outstanding (in Shares)	6,527,227	1,246,589
Class D Incentive Units
Temporary equity, par value (in Dollars per share)	$ 0	$ 0
Temporary equity, shares authorized (in Shares)	1,000,000	1,000,000
Temporary equity, shares issued (in Shares)	50,000	50,000
Temporary equity, shares outstanding (in Shares)	50,000	50,000
Cumulative Preferred Stock
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in Shares)	1,000,000	1,000,000
Preferred stock, shares issued (in Shares)	0	0
Preferred stock, shares outstanding (in Shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Total revenue	$ 802,180	$ 2,120,127	$ 1,581,936	$ 3,974,913
Operating expenses
Selling, general, and administrative	4,489,772	6,097,336	10,417,882	12,269,360
Research and development	1,473,567	2,387,215	3,063,144	4,487,303
Total operating expenses	6,566,054	10,435,667	14,593,185	20,168,683
Operating loss	(5,763,874)	(8,315,540)	(13,011,249)	(16,193,770)
Other income (expense)
Interest income, net	10,736	20,644	19,748	88,981
Change in fair value of warrants liability	1,584,772	143,794	2,312,434	(69,964)
Change in fair value of derivative liability	7,907	83,059	(3,626)	6,219
Other, net	211,444	83,946	4,941	524,332
Total other income, net	1,814,859	331,443	2,333,497	549,568
Loss before taxes	(3,949,015)	(7,984,097)	(10,677,752)	(15,644,202)
Income tax expense	0	0	0	0
Net loss	(3,949,015)	(7,984,097)	(10,677,752)	(15,644,202)
Less: Net (loss) income attributable to non-controlling interests	(10,268)	8,466	(24,566)	14,754
Net loss attributable to Nuvve Holding Corp.	(3,938,747)	(7,992,563)	(10,653,186)	(15,658,956)
Less: Preferred dividends on redeemable non-controlling interests	76,504	70,678	151,508	139,970
Less: Accretion on redeemable non-controlling interests preferred shares	161,466	161,466	322,932	322,932
Net loss attributable to Nuvve Holding Corp. common stockholders	$ (4,176,717)	$ (8,224,707)	$ (11,127,626)	$ (16,121,858)
Net loss per share attributable to Nuvve Holding Corp. common stockholders, basic (in Dollars per share)	$ (0.67)	$ (11.86)	$ (2.15)	$ (24.68)
Net loss per share attributable to Nuvve Holding Corp. common stockholders, diluted (in Dollars per share)	$ (0.67)	$ (11.86)	$ (2.15)	$ (24.68)
Weighted-average shares used in computing net loss per share attributable to Nuvve Holding Corp. common stockholders, basic (in Shares)	6,230,284	693,353	5,172,358	653,245
Weighted-average shares used in computing net loss per share attributable to Nuvve Holding Corp. common stockholders, diluted (in Shares)	6,230,284	693,353	5,172,358	653,245
Products
Revenue
Total revenue	$ 369,192	$ 1,546,723	$ 845,661	$ 2,975,609
Operating expenses
Cost of revenue	256,902	1,311,268	593,574	2,679,841
Services
Revenue
Total revenue	301,567	502,286	521,438	853,785
Operating expenses
Cost of revenue	345,813	639,848	518,585	732,179
Grants
Revenue
Total revenue	$ 131,421	$ 71,118	$ 214,837	$ 145,519

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (3,949,015)	$ (7,984,097)	$ (10,677,752)	$ (15,644,202)
Other comprehensive (loss) income, net of taxes
Foreign currency translation adjustments, net of taxes	(8,093)	1,299	(21,744)	10,233
Total comprehensive loss	(3,957,108)	(7,982,798)	(10,699,496)	(15,633,969)
Less: Comprehensive income (loss) attributable to non-controlling interests	(10,268)	8,466	(24,566)	14,754
Comprehensive loss attributable to Nuvve Holding Corp.	(3,946,840)	(7,991,264)	(10,674,930)	(15,648,723)
Less: Preferred dividends on redeemable non-controlling interests	(76,504)	(70,678)	(151,508)	(139,970)
Less: Accretion on redeemable non-controlling interests preferred shares	(161,466)	(161,466)	(322,932)	(322,932)
Comprehensive loss attributable to Nuvve Holding Corp. common stockholders	$ (3,708,870)	$ (7,759,120)	$ (10,200,490)	$ (15,185,821)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-controlling Interests
Balances (in Shares) at Dec. 31, 2022		606,804
Balances at Dec. 31, 2022	$ 23,245,400	$ 2,427	$ 144,073,505	$ 76,182	$ (116,956,528)	$ (3,950,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)		2,283
Exercise of stock options and vesting of restricted stock	0	$ 9	(9)
Stock-based compensation	1,414,183		1,414,183
Proceeds from Direct Offering, net of offering costs (in shares)		13,587
Proceeds from Direct Offering, net of offering costs	470,000	$ 54	469,946
Proceeds from common stock offering, net of offering costs (in shares)		1,966
Proceeds from common stock offering, net of offering costs	136,717	$ 8	136,709
Currency translation adjustment	8,934			8,934
Preferred dividends - non-controlling interest	(69,292)					(69,292)
Accretion on redeemable non-controlling interests preferred shares	(161,466)					(161,466)
Net loss	(7,660,105)				(7,666,393)	6,288
Balances (in Shares) at Mar. 31, 2023		624,639
Balance at Mar. 31, 2023	17,384,371	$ 2,498	146,094,334	85,116	(124,622,921)	(4,174,656)
Balances (in Shares) at Dec. 31, 2022		606,804
Balances at Dec. 31, 2022	23,245,400	$ 2,427	144,073,505	76,182	(116,956,528)	(3,950,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Currency translation adjustment	10,233
Net loss	(15,644,202)
Balances (in Shares) at Jun. 30, 2023		781,426
Balance at Jun. 30, 2023	13,151,907	$ 3,126	150,076,184	86,415	(132,615,484)	(4,398,334)
Balances (in Shares) at Dec. 31, 2022		606,804
Balances at Dec. 31, 2022	$ 23,245,400	$ 2,427	144,073,505	76,182	(116,956,528)	(3,950,186)
Balances (in Shares) at Dec. 31, 2023	1,246,589	1,246,589
Balance at Dec. 31, 2023	$ 2,580,605	$ 5,927	155,615,962	93,676	(148,240,859)	(4,894,101)
Balances (in Shares) at Mar. 31, 2023		624,639
Balances at Mar. 31, 2023	17,384,371	$ 2,498	146,094,334	85,116	(124,622,921)	(4,174,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)		15,610
Exercise of stock options and vesting of restricted stock	391,191	$ 62	391,129
Stock-based compensation	1,069,188		1,069,188
Proceeds from Direct Offering, net of offering costs (in shares)		107,768
Proceeds from Direct Offering, net of offering costs	1,877,192	$ 432	1,876,760
Proceeds from common stock offering, net of offering costs (in shares)		33,409
Proceeds from common stock offering, net of offering costs	644,907	$ 134	644,773
Currency translation adjustment	1,299			1,299
Preferred dividends - non-controlling interest	(70,678)					(70,678)
Accretion on redeemable non-controlling interests preferred shares	(161,466)					(161,466)
Net loss	(7,984,097)				(7,992,563)	8,466
Balances (in Shares) at Jun. 30, 2023		781,426
Balance at Jun. 30, 2023	$ 13,151,907	$ 3,126	150,076,184	86,415	(132,615,484)	(4,398,334)
Balances (in Shares) at Dec. 31, 2023	1,246,589	1,246,589
Balances at Dec. 31, 2023	$ 2,580,605	$ 5,927	155,615,962	93,676	(148,240,859)	(4,894,101)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)		174,137
Exercise of stock options and vesting of restricted stock	0	$ 18	(18)
Stock-based compensation	846,514		846,514
Proceeds from common stock offering, net of offering costs (in shares)		3,035,000
Proceeds from common stock offering, net of offering costs	5,029,422	$ 304	5,029,118
Issuance of Pre-funded Warrants (in shares)		1,614,916
Issuance of Pre-funded Warrants	108	$ 108
Currency translation adjustment	(13,651)			(13,651)
Preferred dividends - non-controlling interest	(75,004)					(75,004)
Accretion on redeemable non-controlling interests preferred shares	(161,466)					(161,466)
Net loss	(6,728,737)				(6,714,438)	(14,299)
Balances (in Shares) at Mar. 31, 2024		6,070,642
Balance at Mar. 31, 2024	$ 1,477,791	$ 6,357	161,491,576	80,025	(154,955,297)	(5,144,870)
Balances (in Shares) at Dec. 31, 2023	1,246,589	1,246,589
Balances at Dec. 31, 2023	$ 2,580,605	$ 5,927	155,615,962	93,676	(148,240,859)	(4,894,101)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Currency translation adjustment	(21,744)
Net loss	$ (10,677,752)
Balances (in Shares) at Jun. 30, 2024	6,527,227	6,527,227
Balance at Jun. 30, 2024	$ (2,062,490)	$ 6,403	162,146,327	71,932	(158,894,044)	(5,393,108)
Balances (in Shares) at Mar. 31, 2024		6,070,642
Balances at Mar. 31, 2024	1,477,791	$ 6,357	161,491,576	80,025	(154,955,297)	(5,144,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)		6,606
Exercise of stock options and vesting of restricted stock	0	$ 1	(1)
Stock-based compensation	481,800		481,800
Issuance of Pre-funded Warrants (in shares)		149,979
Issuance of Pre-funded Warrants	0	$ 15	(15)
Exercise of Warrants (in shares)		300,000
Exercise of Warrants	172,997	$ 30	172,967
Currency translation adjustment	(8,093)			(8,093)
Preferred dividends - non-controlling interest	(76,504)					(76,504)
Accretion on redeemable non-controlling interests preferred shares	(161,466)					(161,466)
Net loss	$ (3,949,015)				(3,938,747)	(10,268)
Balances (in Shares) at Jun. 30, 2024	6,527,227	6,527,227
Balance at Jun. 30, 2024	$ (2,062,490)	$ 6,403	$ 162,146,327	$ 71,932	$ (158,894,044)	$ (5,393,108)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net loss	$ (3,949,015)	$ (6,728,737)	$ (7,984,097)	$ (7,660,105)	$ (10,677,752)	$ (15,644,202)
Adjustments to reconcile to net loss to net cash used in operating activities
Depreciation and amortization					179,170	156,290
Stock-based compensation					1,390,808	2,069,227
Change in fair value of warrants liability	(1,584,772)		(143,794)		(2,312,434)	69,964
Change in fair value of derivative liability					3,626	(6,219)
Warrants issuance costs					305,065	0
Gains from sale of investments in equity securities					0	(325,155)
Noncash lease expense					252,997	233,730
Change in operating assets and liabilities
Accounts receivable					1,208,706	(903,652)
Inventory					(154,683)	2,612,535
Prepaid expenses and other assets					921,517	249,728
Accounts payable					175,202	(1,595,737)
Due to customers					0	2,980,318
Accrued expenses and other liabilities					(74,049)	1,195,845
Deferred revenue					45,261	(140,783)
Net cash used in operating activities					(8,736,566)	(9,048,111)	$ (21,300,000)	$ (34,100,000)
Investing activities
Purchase of property and equipment					(53,103)	(101,775)
Proceeds from sale of investments in equity securities					0	1,325,155
Net cash (used) provided in investing activities					(53,103)	1,223,380
Financing activities
Proceeds from exercise of warrants					172,997	0
Proceeds from Direct Offering of common stock, net of issuance costs					0	2,347,192
Proceeds from common stock offering, net of issuance costs					8,516,741	781,624
Payment of finance lease obligations					(5,477)	(4,480)
Net cash provided in financing activities					8,684,261	3,124,336
Effect of exchange rate on cash					2,162	5,503
Net decrease in cash and restricted cash					(103,246)	(4,694,892)
Cash and restricted cash at beginning of year		$ 2,014,660		$ 16,233,896	2,014,660	16,233,896	16,233,896
Cash and restricted cash at end of period	$ 1,911,414		$ 11,539,004		$ 1,911,414	$ 11,539,004	$ 2,014,660	$ 16,233,896

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business Nuvve Holding Corp., a Delaware corporation headquartered in San Diego, California (the “Company” or “Nuvve”), was founded on November 10, 2020 under the laws of the state of Delaware. On March 19, 2021, the Company (at the time known as NB Merger Corp.) acquired the outstanding shares of Nuvve Corporation (“Nuvve Corp.”), and the Company changed its name to Nuvve Holding Corp. Reverse Stock Split At the Company’s Special Meeting of Stockholders held on January 5, 2024, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio within the range of 1-for-2 to 1-for-40. The Board approved a 1-for-40 reverse split ratio, and on January 19, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect the reverse split effective January 19, 2024. The reverse stock split is also applicable to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable are adjusted proportionately as a result of the reverse stock spli t. The exercise prices of any outstanding warrants or stock options will also be proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans. The re verse stock split did not affect the number of authorized shares of the Company's common stock or the par value of the common stock. All issued and outstanding common stock, options to purchase common stock, warrants to purchase common stock and per share amounts contained in the condensed consolidated financial statement have been retroactively adjusted to reflect the reverse stock split for all periods presented. Structure of the Company Nuvve has two wholly owned subsidiaries, Nuvve Corp. and Nuvve Pennsylvania LLC. Nuvve Corp. has four wholly owned subsidiaries: (1) Nuvve Denmark ApS, (“Nuvve Denmark”), a company registered in Denmark, (2) Nuvve SaS, a company registered in France, (3) Nuvve KK (Nuvve Japan), a company registered in Japan, and (4) Nuvve LTD, a company registered in United Kingdom. Nuvve Norway, a company registered in Norway is a branch of Nuvve Denmark. On August 4, 2021, the Company formed Levo Mobility LLC, a Delaware limited liability company ("Levo"), with Stonepeak Rocket Holdings LP, a Delaware limited partnership ("Stonepeak"), and Evolve Transition Infrastructure LP, a Delaware limited partnership ("Evolve"). Levo is a consolidated entity of the Company. Please see Note 2 for the principles of consolidation. Levo is a sustainable infrastructure company focused on rapidly advancing the electrification of transportation by funding vehicle-to-grid ("V2G") enabled Electric Vehicle ("EV") fleet deployments. Levo utilizes Nuvve’s V2G technology and conditional capital contribution commitments from Stonepeak and Evolve to offer Fleet-as-a-Service ("FaaS") for school buses, last-mile delivery, ride hailing and ride sharing, municipal services, and more to eliminate the primary barriers to EV fleet adoption including large upfront capital investments and lack of expertise in securing and managing EVs and associated charging infrastructure. Levo's turnkey solution simplifies and streamlines electrification, can lower the total cost of EV operation for fleet owners, and supports the grid when the EVs are not in use. For a fixed monthly payment with no upfront cost, Levo will provide the EVs, such as electric school buses, charging infrastructure powered by Nuvve’s V2G platform, EV and charging station maintenance, energy management, and technical advice. Levo focuses on electrifying school buses, providing associated charging infrastructure, and delivering V2G services to enable safer and healthier transportation for children while supporting carbon dioxide emission reduction, renewable energy integration, and improved grid resiliency.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, see Note 2, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). During the six months ended June 30, 2024, there were no significant updates made to the Company’s significant accounting policies. Basis of Presentation The accompanying (i) unaudited condensed consolidated balance sheet as of December 31, 2023, which has been derived from audited financial statements, and (ii) unaudited interim condensed consolidated financial statements have been prepared in accordance pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. Therefore, it is recommended that these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the 2023 Form 10-K, filed with the SEC on March 28, 2024. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, cash flows, and total equity for the interim periods, but are not necessarily indicative of the results to be anticipated for the full year 2024 or any future period. In accordance with the related Going Concern accounting standards, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. Since inception, the Company has incurred recurring losses and negative cash flows from operations and has an accumulated deficit o f $158.9 million and $148.2 million as of June 30, 2024 and December 31, 2023, respectively. The Company incurred operating losses of approximately $13.0 million as of the six months ended June 30, 2024, and $32.1 million and $36.9 million for the years ended December 31, 2023, and 2022, respectively. The Company's cash used in operations were $8.7 million for the six months ended June 30, 2024, and $21.3 million and $34.1 million for the years ended December 31, 2023, and 2022, respectively. As of June 30, 2024, the Company had a cash balance, working capital, and total equity of $1.4 million, $2.6 million and $2.7 million, respectively. The Company continues to expect to generate operating losses and negative cash flows and will need additional funding to support its planned operating activities through profitability. The transition to profitability is dependent upon the successful expanded commercialization of the Company's GIVe platform and the achievement of a level of revenues adequate to support its cost structure. Management plans to fund current operations through increased revenues and raising additional capital. Management's expectations with respect to the Company’s ability to fund current planned operations is based on estimates that are subject to risks and uncertainties. There is an inherent risk that the Company may not achieve such financial projections and if so, cash outflows could be higher than currently anticipated. However, as such, plans are not solely within management’s control, management cannot conclude as of the date of this filing that the plans are probable of being successfully implemented and as such has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for twelve months from the date of issuance of our financial statements. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Principles of Consolidation The condensed consolidated financial statements include the accounts and operations of the Company, its wholly owned subsidiaries and its consolidated variable interest entity. All intercompany accounts and transactions have been eliminated upon consolidation. Variable Interest Entities Pursuant to the consolidation guidance, the Company first evaluates whether it holds a variable interest in an entity in which it has a financial relationship and, if so, whether or not that entity is a variable interest entity ("VIE"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company formed Levo with Stonepeak and Evolve, in which the Company owns 51% of Levo's common units. The Company has determined that Levo is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates Levo and records a non-controlling interest for the share of the entity owned by Stonepeak and Evolve. Assets and Liabilities of Consolidated VIEs The Company's condensed consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net income (loss) attributable to non-controlling interests" in the condensed consolidated statements of operations and "Non-controlling interests" in the condensed consolidated balance sheets. See Note 18 for details of non-controlling interests. The Company began consolidating the assets, liabilities and results of operations of Levo during the quarter ended September 30, 2021. The creditors of the consolidated VIE do not have recourse to the Company other than to the assets of the consolidated VIE. The following table summarizes the carrying amounts of Levo assets and liabilities included in the Company’s condensed consolidated balance sheets at June 30, 2024 and December 31, 2023: June 30, 2024 December 31, 2023 Assets Cash $ 4,953 $ 27,337 Prepaid expenses and other current assets 341 1,363 Total Assets $ 5,294 $ 28,700 Liabilities Accounts payable $ 24,280 $ 8,380 Accrued expenses and dividend payable 761,329 620,421 Derivative liability - non-controlling redeemable preferred shares 313,354 309,728 Total Liabilities $ 1,098,963 $ 938,529 Redeemable Non-Controlling Interest - Mezzanine Equity Redeemable non-controlling interest represents the shares of the preferred stock issued by Levo to Stonepeak and Evolve (the "preferred shareholders"), who own 49% of Levo common units. The preferred stock is not mandatorily redeemable or currently redeemable, but it could be redeemable with the passage of time at the election of Levo, the preferred shareholders or a triggering event as defined in the preferred stock agreement. As a result of the contingent put right available to the preferred shareholders, the redeemable non-controlling interests in Levo are classified as mezzanine equity in the Company’s unaudited condensed consolidated balance sheets. The initial carrying value of the redeemable non-controlling interest is reported at the initial proceeds received on issuance date, reduced by the fair value of embedded derivatives resulting in an adjusted initial carrying value. The adjusted initial carrying value is further adjusted for the accretion of the difference with the redemption price value using the effective interest method. The accretion amount is a deemed dividend recorded against retained earnings or, in its absence, to additional paid-in-capital. The carrying amount of the redeemable non-controlling interest is measured at the higher of the carrying amount adjusted each reporting period for income (or loss) attributable to the non-controlling interest, or the carrying amount adjusted each reporting period by the accretion amount. See Note 18 for details. Non-controlling interests The Company presents non-controlling interests as a component of equity on its condensed consolidated balance sheets and reports the portion of its earnings or loss for non-controlling interest as net earnings or loss attributable to non-controlling interests in the condensed consolidated statements of operations. Emerging Growth Company Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies (“EGC”) to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The Company qualifies as an EGC. The JOBS Act provides that an EGC can elect to opt-out of the extended transition period and comply with the requirements that apply to non-EGCs, but any such election to opt-out is irrevocable. The Company has elected not to opt-out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an EGC, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This different adoption timing may make a comparison of the Company’s financial statements with another public company, which is neither an EGC nor an EGC that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include the impairment of intangible assets, the net realizable value of inventory, the fair value of share-based payments, lease incremental borrowing rate, derivative liability associated with redeemable preferred shares, revenue recognition, the fair value of warrants, annual bonus accrual, and the recognition and disclosure of contingent liabilities. Management evaluates its estimates on an ongoing basis. Actual results could materially vary from those estimates. Cash and Restricted Cash The Company maintains cash balances that can, at times, exceed amounts insured by the Federal Deposit Insurance Corporation, which is up to $250,000. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk in this area. In connection with a new office lease agreement, the Company was required to provide an irrevocable, unconditional letter of credit to the landlord upon execution of the lease. The amount securing the letter of credit was recorded as restricted cash as of June 30, 2024 and December 31, 2023 was $480,000 . Concentrations of Credit Risk At June 30, 2024 and December 31, 2023, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits) and trade receivables. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the three and six months ended June 30, 2024 three customers accounted for 57.1% and 44.7% of revenue, respectively. For the three and six months ended June 30, 2023 two and one customer accounted for 28.4% and 27.5% o f revenue, respectively. During the three and six months ended June 30, 2024, the Company's top five customers accounted for approximately 75.4% and 62.4% o f the Company’s total revenue, respectively. During the three and six months ended June 30, 2023, the Company's top five customers accounted for approximately 53.5% and 52.1% o f the Company’s total revenue, respectively. At June 30, 2024, three customers accounted for 68.9% of accounts receivable. At December 31, 2023, three customers accounted for 60.9% of a ccounts receivable. Approximat ely 95.0% and 74.0% of the Company’s trade accounts receivable balance was with five customers at June 30, 2024 and December 31, 2023 , respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all probable bad debt losses have been appropriately considered in establishing the allowance for doubtful accounts. Recently adopted accounting pronouncements None Applicable Recently issued accounting pronouncements not yet adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the Company’s CODM. The amendments in this update also provide new segment disclosure requirements for entities with a single reportable segment, and expand the interim segment disclosure requirements. ASU 2023-07 is effective for the fiscal year ending December 31, 2024 and for the Company’s interim periods beginning with the first quarter ended 2025. Early adoption is permitted and the amendments in this update are required to be applied on a retrospective basis. The Company is currently evaluating the impact of this guidance on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures . ASU 2023-09 requires disclosure of disaggregated income taxes paid in both U.S. and foreign jurisdictions, prescribes standard categories for the components of the effective tax rate reconciliation and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company’s fiscal year ending December 31, 2025. Early adoption is permitted and the amendments in this update should be applied on a prospective basis, though retrospective adoption is permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The disclosures below discuss the Company’s material revenue contracts. The following table provides information regarding disaggregated revenue: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenue recognized over time: Services - engineering and others $ 186,269 $ 409,895 $ 366,500 $ 631,731 Grid services 115,298 92,391 154,938 222,054 Grants 131,421 71,118 214,837 145,519 Revenue recognized at point in time: Products 369,192 1,546,723 845,661 2,975,609 Total revenue $ 802,180 $ 2,120,127 $ 1,581,936 $ 3,974,913 The aggregate amount of revenue for the Company’s existing contracts and grants with customers as of June 30, 2024 expected to be recognized in the future, and classified as deferred revenue on the condensed consolidated balance sheet, for year ended December 31, is as follows (this disclosure does not include revenue related to contracts whose original expected duration is one year or less): 2024 (remaining six months) 386,817 2025 286,168 2026 148,109 2027 113,197 Thereafter 135,687 Total (1) $ 1,069,978 __________________ (1) The revenue recognition is subject to the completion of construction and commissioning of the EV infrastructure. The Company operates in a single business segment, which is the EV V2G Charging segment. The following table summarizes the Company’s revenues by geography: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenues: United States $ 746,454 $ 1,979,610 $ 1,502,064 $ 3,738,063 United Kingdom — — — 33,483 Denmark 55,726 140,517 79,872 203,367 $ 802,180 $ 2,120,127 $ 1,581,936 $ 3,974,913 The following table summarizes the Company’s intangible assets and property, plant and equipment in different geographic locations: June 30, December 31, Long-lived assets: United States $ 1,649,866 $ 1,741,009 United Kingdom 2,154 2,894 Denmark 190,380 224,564 $ 1,842,400 $ 1,968,467

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following are the liabilities measured at fair value on the condensed consolidated balance sheet at June 30, 2024 and December 31, 2023 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2024 Total Gains (Losses) For The Six Months Ended June 30, 2024 Recurring fair value measurements Private warrants $ — $ — $ — $ — $ — $ — Stonepeak and Evolve unvested warrants $ — $ — $ — $ — $ — $ — 2022 July Institutional/Accredited Investor warrants $ — $ — $ 3 $ 3 $ 3 $ 4,621 2024 February Institutional/Accredited Investor warrants $ — $ — $ 1,484,504 $ 1,484,504 $ 1,584,770 $ 2,307,813 Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 313,354 $ 313,354 $ 7,907 $ (3,626) Total recurring fair value measurements $ — $ — $ 1,797,861 $ 1,797,861 $ 1,592,680 $ 2,308,808 Level 1: Level 2: Level 3: Total at December 31, Total Gains (Losses) For The Three Months Ended June 30, 2023 Total Gains (Losses) For The Six Months Ended June 30, 2023 Recurring fair value measurements Private warrants $ — $ — $ — $ — $ 784 $ 1,784 Stonepeak and Evolve unvested warrants $ — $ — $ — $ — — — 2022 July Institutional/Accredited Investor warrants $ — $ — $ 4,621 $ 4,621 $ 143,010 $ (71,748) Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 309,728 $ 309,728 $ 83,059 $ 6,219 Total recurring fair value measurements $ — $ — $ 314,349 $ 314,349 $ 226,853 $ (63,745) The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11 ) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2024: Private warrants Stonepeak and Evolve unvested warrants 2022 July Institutional/Accredited Investor warrants 2024 February Institutional/Accredited Investor warrants Non-controlling redeemable preferred shares - derivative liability Balance at December 31, 2023 $ — $ — $ 4,621 $ — $ 309,728 Initial fair value — — — 3,792,317 — Total (gains) losses for period included in earnings — — (4,619) (723,043) 11,533 Balance at March 31, 2024 — — 3 3,069,274 321,261 Total (gains) losses for period included in earnings — — (3) (1,584,770) (7,907) Balance at June 30, 2024 $ — $ — $ — $ 1,484,504 $ 313,354 The fair value of the level 3 Private Warrants was estimated at June 30, 2024 using the Black-Scholes model which used the following inputs: term of 1.72 years , risk free rate of 4.82% , no dividends, volatility of 46.0% , and strike price of $460.00 . The fair value of the level 3 Private Warrants was estimated at December 31, 2023 using the Black-Scholes model which used the following inputs: term of 2.22 years, risk free rate of 4.20%, no dividends, volatility of 60.0%, and strike price of $460.00. The fair value of the level 3 2022 July Institutional/Accredited Investor warrants was estimated at June 30, 2024 using the Black-Scholes model which used the following inputs: term of 3.60 years , risk free rate of 4.47% , no dividends, volatility of 57.0% , common stock price of $0.80 , and strike price of $150.00 . The fair value of the level 3 2022 July Institutional/Accredited Investor warrants was estimated at December 31, 2023 using the Black-Scholes model which used the following inputs: term of 4.10 years, risk free rate of 3.92%, no dividends, volatility of 63.0%, common stock price of $0.12, and strike price of $150.00. The fair value of the level 3 2024 February Institutional/Accredited Investor warrants was estimated at June 30, 2024 using the Black-Scholes model which used the following inputs: term of 4.60 years, risk free rate of 4.37%, no dividends, volatility of 99.0%, common stock price of $0.80, and strike price of $2.00. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2024: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Capital expenditure forecast (in millions) $— $— $— $— Probability of warrants vesting (a) —% —% —% —% __________________ (a) During the second quarter ended June 30, 2022, the Company significantly lowered its forecast of Levo's capital deployments due to the passage by the United States Congress of the Infrastructure Investment and Jobs Act bill, and the related unveiling of the Environmental Protection Agency’s 2022 Clean School Bus rebates. The resulting lower forecast of capital deployments reduced the probabilities of the future vesting of the unvested warrants. Therefore, at June 30, 2024, the Company has determined that it is unlikely that the unvested warrants will vest. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at December 31, 2023: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Capital expenditure forecast (in millions) $— $— $— $— Probability of warrants vesting (a) —% —% —% —% __________________ (a) During the second quarter ended June 30, 2022, the Company significantly lowered its forecast of Levo's capital deployments due to the passage by the United States Congress of the Infrastructure Investment and Jobs Act bill, and the related unveiling of the Environmental Protection Agency’s 2022 Clean School Bus rebates. The resulting lower forecast of capital deployments reduced the probabilities of the future vesting of the unvested warrants. Therefore, at December 31, 2023, the Company has determined that it is unlikely that the unvested warrants will vest. The fair value of the level 3 derivative liability - non-controlling redeemable preferred shares are estimated at June 30, 2024 using the M onte Carlo Simulation model which used the following inputs: terms range from 0.09 years to 7.0 years, risk free rate of 4.4% , no dividends, volatility of 101.0% and probability of redemptions triggered of 75.0% . The fair value of the level 3 derivative liability - non-controlling redeemable preferred shares are estimated at December 31, 2023 using the M onte Carlo Simulation model which used the following inputs: terms range from 0.60 years to 7.0 years, risk free rate of 3.9%, no dividends, volatility of 79.0% and probability of redemptions triggered of 75.0%. There were no transfers between Level 1 and Level 2 of the fair value hierarchy in 2024 and 2023. Cash, accounts receivable, accounts payable, and accrued expenses are generally carried on the cost basis, which management believes approximates fair value due to the short-term maturity of these instruments.

Derivative Liability - Non-Cont

Derivative Liability - Non-Controlling Redeemable Preferred Stock	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability - Non-Controlling Redeemable Preferred Stock	Derivative Liability - Non-Controlling Redeemable Preferred Stock The Company has determined that the redemption features embedded in the non-controlling redeemable preferred stock is required to be accounted for separately from the redeemable preferred stock as a derivative liability. Separation of the redemption features as a derivative liability is required because its economic characteristics and risks are considered more akin to a debt instrument, and therefore, not considered to be clearly and closely related to the economic characteristics of the redeemable preferred stock. The economic characteristics of the redemption features are considered more akin to a debt instrument because the minimum redemption value could be greater than the face amount, the redemption features are contingently exercisable, and the shares carry a fixed mandatory dividend. Accordingly, the Company has recorded an embedded derivative liability representing the estimated fair value of the right of the holders to exercise their redemption option upon the occurrence of a redemption event. The embedded derivative liability is adjusted to reflect fair value at each period end with changes in fair value recorded in the “ Change in fair value of derivative liability” financial statement line item of the Company’s condensed consolidated statements of operations Note 18 . The following table displays the fair value of derivatives by balance sheet line item: June 30, 2024 December 31, 2023 Derivative liability - non-controlling redeemable preferred shares $ 313,354 $ 309,728

Investments

Investments	6 Months Ended
	Jun. 30, 2024
Investments [Abstract]
Investments	Investments The Company accounts for its 13% equity ownership in Dreev as an investment in equity securities without a readily determinable fair value subject to impairment. The Company has a consulting services agreement with Dreev related to software development and operations. The consulting services were zero fo r the three and six months ended June 30, 2024. The consulting services were zero fo r the three and six months ended June 30, 2023. The consulting services are being provided to Dreev at the Company’s cost and is recognized as other income, net in the condensed consolidated statements of operations.

Account Receivables, Net

Account Receivables, Net	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Account Receivables, Net	Account Receivables, Net The following tables summarizes the Company's accounts receivable: June 30, 2024 December 31, 2023 Trade receivables $ 831,909 $ 2,107,497 Less: allowance for credit losses (315,716) (382,598) Accounts receivable, net $ 516,193 $ 1,724,899 Allowance for credit losses: Balance December 31, 2023 $ (382,598) Provision (41,175) Write-off — Recoveries 108,057 Balance at June 30, 2024 $ (315,716)

Inventories

Inventories	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories The following table summarizes the Company’s inventories balance by category: June 30, 2024 December 31, 2023 DC Chargers $ 5,357,368 $ 5,275,934 AC Chargers 446,357 236,316 Component parts and Carbon Credit 240,411 377,203 Total $ 6,044,136 $ 5,889,453

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment The following table summarizes the Company’s property, plant and equipment balance: Useful Lives June 30, 2024 December 31, 2023 Computers & Servers 1 year to 3 years $ 169,528 $ 154,337 Vehicles 5 years to 7 years 65,492 65,577 Office furniture and equipment 3 years to 5 years 366,323 366,323 Test units and loaned chargers (1) 5 years to 7 years 628,032 598,820 Total 1,229,375 1,185,057 Less: Accumulated Depreciation (519,459) (418,793) Property, plant and equipment, net $ 709,916 $ 766,264 Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Depreciation expense $ 51,088 $ 46,571 $ 102,884 $ 96,529 __________________

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets At both June 30, 2024 and December 31, 2023, the Company had recorded a gross intangible asset balance of $2,091,556, which is related to patent and intangible property rights acquired. Amortization expense of intangible assets was $34,860 for each of the three months ended June 30, 2024 and 2023. Amortization expense of intangible assets was $69,719 for each of the six months ended June 30, 2024 and 2023. Accumulated amortization totaled $959,072 and $889,353 at June 30, 2024 and December 31, 2023, respectively. The net amount of intangible assets of $1,132,483 at June 30, 2024, will be amortized over the weighted average remaining life of 8.3 years . Total estimated future amortization expense is as follows: 2024 (remaining six months) $ 69,717 2025 139,437 2026 137,770 2027 132,770 2028 132,770 Thereafter 520,019 $ 1,132,483

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Stockholders’ Equity (Deficit)	Stockholders’ Equity (Deficit) Reverse Stock Split The reverse stock split did not affect the number of authorized shares of the Company's common stock or the par value of the common stock. Following the reverse stock split effectiveness on January 19, 2024, all references in the condensed consolidated financial statements to number of common shares issued or outstanding, price per share and weighted average number of shares outstanding prior to the 1- for - 40 reverse split have been adjusted to reflect the stock split on a retroactive basis as of the earliest period presented. Authorized Shares As of June 30, 2024, the Company has authorized two classes of stock, Common Stock, and Preferred Stock. The total number of shares of all classes of capital stock which the Company has authority to issue is 101,000,000, of which 100,000,000 authorized shares are Common Stock with a par value of $0.0001 per share (“Common Stock”), and 1,000,000 authorized shares are Preferred Stock of the par value of $0.0001 per share (“Preferred Stock”). Please see Note 11, “ Stockholders' Equity ,” in the Notes to Consolidated Financial Statements included in the Company’s 2023 Form 10-K for a detailed discussion of the Company’s stockholders' equity. February 2024 Public Offering On January 31, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Craig-Hallum Capital Group LLC (“Craig-Hallum”) regarding an underwritten public offering of its securities (the “Offering”). The Offering was conducted pursuant to our Registration Statement on Form S-1 filed with the SEC, which was declared effective as of January 31, 2024. On February 2, 2024, the Company completed the Offering and received gross proceeds of approximately $9.6 million prior to deducting underwriting discounts and commissions and offering expenses. Craig-Hallum received underwriting discounts and commissions equal to 7.0% of the gross proceeds of the Offering, and is further entitled to receive 7.0% of the gross proceeds received by the Company in connection with the exercise of any of the outstanding Series B Warrants issued in the Offering. As noted above, on January 31, 2024, the Company entered into an Underwriting Agreement regarding the Offering which was comprised of the followings: 1. 3,035,000 shares of common stock; 2. 1,765,000 pre-funded warrants (“Pre-Funded Warrants”) to purchase shares of common stock; 3. 4,800,000 Series A Warrants (“Series A Warrants”) to purchase shares of common stock, with an initial exercise price of $2.00 per share and a term of five years following the issuance date; 4. 4,800,000 Series B Warrants (“Series B Warrants”) to purchase shares of common stock with an exercise price of $2.00 per share and a term of nine months following the issuance date; and 5. 4,800,000 Series C Warrants (“Series C Warrants”) to purchase shares of common stock with an exercise price of $2.00 per share and a term of five years following the issuance date, subject to early expiration as described below. Each share of common stock and Pre-Funded Warrant issued in the Offering was accompanied by a Series A Warrant to purchase one share of common stock, a Series B Warrant to purchase one share of common stock and a Series C Warrant to purchase one share of common stock. The combined price per share of Common Stock and the accompanying Series A Warrant, Series B Warrant and Series C Warrant was $2.00. The combined price per share of each Pre-Funded Warrant and accompanying Series A Warrant, Series B Warrant, and Series C Warrant was equal to $1.9999, and the exercise price of each Pre-Funded Warrant is $0.0001 per share. The Series C Warrants may only be exercised to the extent and in proportion to a holder of the Series C Warrants exercising its Series B Warrants, and are subject to an early expiration of nine months, in proportion and only to the extent any Series C Warrants expire unexercised. In addition, Craig-Hallum was granted warrants to purchase up to 480,000 shares of common stock (the “Underwriter Warrants”) at an exercise price of $2.00 per share. The Underwriter Warrants have a term of five years and are immediately exercisable, provided that 240,000 of the shares of common stock underlying the Underwriter Warrants shall only be exercisable pro rata upon the exercise of the Series B Warrants issued in the Offering. The fair value of the Series A, B and C Warrants are recorded as a liability in the condensed consolidated balance sheets with changes in fair value recorded in the condensed consolidated statements of operations as the warrants are deemed not to be indexed to the Company’s common stock. See Note 4 for details of changes in fair value of the warrants recorded in the condensed consolidated statement of operations. Warrants - Stonepeak and Evolve On May 17, 2021, in connection with the signing of a letter of agreement, relating to the formation of Levo (the "Letter Agreement"), the Company issued to Stonepeak and Evolve ten year warrants to purchase common stock (allocated 90% to Stonepeak and 10% to Evolve). See below for details. The grant-date fair value of the warrants issued to Stonepeak and Evolve were: series B $12.8 million, series C $5.6 million, series D $4.8 million, series E $3.8 million and series F $3.2 million. The fair values of the vested warrants are recorded in the condensed consolidated balance sheets in additional paid-in capital in stockholders' equity as the vested warrants are indexed to the Company’s common stock and meet the conditions for equity classification. The unvested warrants are recorded as a liability in the condensed consolidated balance sheets at fair value, with changes in fair value recorded in the condensed consolidated statements of operations as the unvested warrants are deemed not to be indexed to the Company’s common stock. See Note 4 for details of changes in fair value of the unvested warrants recorded in the condensed consolidated statement of operations. The Company issued to Stonepeak and Evolve the following ten year warrants to purchase common stock (allocated 90% to Stonepeak and 10% to Evolve): • Series B warrants to purchase 50,000 shares of the Company’s common stock, at an exercise price of $400.00 per share, which are fully vested upon issuance, • Series C warrants to purchase 25,000 shares of the Company’s common stock, at an exercise price of $600.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $125 million in aggregate capital expenditures, • Series D warrants to purchase 25,000 shares of the Company’s common stock, at an exercise price of $800.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $250 million in aggregate capital expenditures, • Series E warrants to purchase 25,000 shares of the Company’s common stock, at an exercise price of $1,200.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $375 million in aggregate capital expenditures, and • Series F warrants to purchase 25,000 shares of the Company’s common stock, at an exercise price of $1,600.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $500 million in aggregate capital expenditures. The warrants may be exercised at any time on or after the date that is 180 days after the applicable vesting date. Securities Purchase Agreement On May 17, 2021, in connection with the signing of the Letter Agreement, the Company entered into a Securities Purchase Agreement with Stonepeak and Evolve which provide them from time to time between November 13, 2021 and November 17, 2028, in their sole discretion, to purchase up to an aggregate of $250 million in shares of the Company’s common stock at a purchase price of $2,000.00 per share (allocated 90% to Stonepeak and 10% to Evolve). See below f or details. The grant-date fair value of the Securities Purchase Agreement to purchase shares of the Company’s common stock was $12.6 million, and is recorded in the condensed consolidated balance sheets as equity in additional-paid-in capital as it is indexed to the Company’s common stock and meets the conditions for equity classification . In connection with the signing of the Letter Agreement, as referenced above, the Company also entered into a Securities Purchase Agreement (the “SPA”) and a Registration Rights Agreement (the “RRA”) with Stonepeak and Evolve. • The SPA includes customary representations and warranties and closing conditions and customary indemnification provisions. In addition, Stonepeak and Evolve may elect to purchase shares under the SPA on a cashless basis in the event of a change of control of the Company. Warrants - Public and Private In connection with its initial public offering on February 19, 2020, Newborn sold 143,750 units, which included one warrant to purchase Newborn’s common stock (the “Public Warrants”). Also, on February 19, 2020, NeoGenesis Holding Co., Ltd., Newborn’s sponsor (“the Sponsor”), purchased an aggregate of 6,813 private units, each of which included one warrant (the “Private Warrants”), which have the same terms as the Public Warrants. Upon completion of the merger between Nuvve and Newborn, the Public Warrants and Private Warrants were automatically converted to warrants to purchase Common Stock of the Company. The terms of the Private Warrants are identical to the Public Warrants as described above, except that the Private Warrants are not redeemable so long as they are held by the Sponsor or its permitted transferees. Concurrently with the execution of the Merger Agreement on November 11, 2020, Newborn entered into subscription agreements with certain accredited investors pursuant to which the investors agreed to purchase 35,625 of Newborn’s common stock, at a purchase price of $400.00 per share, for an aggregate purchase price of $14,250,000 (the "PIPE"). Upon closing of the PIPE immediately prior to the closing of the Business Combination, the PIPE investors also received 1.9 PIPE Warrants to purchase the Company’s Common Stock for each share of Common Stock purchased. The PIPE Warrants are each exercisable for one-half of a common share at $460.00 per share and have the same terms as described above for the Public Warrants. The PIPE investors received demand and piggyback registration rights in connection with the securities issued to them. Because the Private Warrants have dissimilar terms with respect to the Company’s redemption rights depending on the holder of the Private Warrants, the Company determined that the Private Warrants are required to be carried as a liability in the condensed consolidated balance sheet at fair value, with changes in fair value recorded in the condensed consolidated statement of operations. The Private Warrants are reflected as a liability in the condensed consolidated balance sheet as of June 30, 2024 and the change in the fair value of the Private Warrants is reflect ed in the condensed consolidated statement of operations. See Note 4 for details of changes in fair value of the Private Warrants recorded in the condensed consolidated statement of operations. The following table is a summary of the number of shares of the Company’s Common Stock issuable upon exercise of warrants outstanding at June 30, 2024: Number of Number of Number of Exercise Expiration Public Warrants 71,875 — 71,875 $460.00 March 19, 2026 Private Warrants 3,406 — 3,406 $460.00 March 19, 2026 PIPE Warrants 33,844 — 33,844 $460.00 March 19, 2026 Stonepeak/Evolve Warrants - series B 50,000 — 50,000 $400.00 May 17, 2031 Stonepeak/Evolve Warrants - series C 25,000 — 12,500 $600.00 May 17, 2031 Stonepeak/Evolve Warrants - series D 25,000 — 12,500 $800.00 May 17, 2031 Stonepeak/Evolve Warrants - series E 25,000 — 12,500 $1,200.00 May 17, 2031 Stonepeak/Evolve Warrants - series F 25,000 — 12,500 $1,600.00 May 17, 2031 2022 July Institutional/Accredited Investor Warrants 100,000 — 100,000 $150.00 January 29, 2028 2024 February Institutional/Accredited Investor Pre-Funded Warrants 575,000 575,000 — $0.0001 February 2, 2029 2024 February Institutional/Accredited Investor Warrants - series A 4,800,000 — 4,800,000 $2.00 February 2, 2029 2024 February Institutional/Accredited Investor Warrants - series B 4,800,000 300,000 4,500,000 $2.00 November 2, 2024 2024 February Institutional/Accredited Investor Warrants - series C 4,800,000 — 4,800,000 $2.00 February 2, 2029 15,334,125 875,000 14,409,125 Unit Purchase Option On February 19, 2020, Newborn sold to the underwriters of its initial public offering for $100, a unit purchase option ("UPO") to purchase up to a total of 7,906 units at $460.00 per unit (or an aggregate exercise price of $3,636,875) commencing on the date of Newborn's initial business combination, March 19, 2021, and expiring February 13, 2025. Each unit issuable upon exercise of the UPO consists of one and one-tenth of a share of the Company's common stock and one warrant to purchase one share of the Company's common stock at the exercise price of $460.00 per share. The warrant has the same terms as the Public Warrant. In no event will the Company be required to net cash settle the exercise of the UPO or the warrants underlying the UPO. The holders of the unit purchase option have demand and "piggy back" registration rights for periods of five ASC 815-40, Derivatives and Hedging-Contracts in an Entity’s Own Equity, as the UPO is indexed to the Company’s common stock and meets the conditions for equity classification.

Stock Option Plan

Stock Option Plan	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Option Plan	Stock Option Plan In 2010, the Company adopted the 2010 Equity Incentive Plan (the “2010 Plan”), which provides for the grant of restricted stock awards, stock options, and other share-based awards to employees, consultants, and directors. In November 2020, the Company’s Board of Directors extended the term of the 2010 Plan to July 1, 2021. In 2021, the Company adopted the 2020 Equity Incentive Plan (the “2020 Plan”), which provides for the grant of restricted stock awards, incentive and non-statutory stock options, and other share-based awards to employees, consultants, and directors. In June 2023, the 2020 Plan was amended, as approved by shareholders, to increase the common shares reserved for issuance under the plan by 100,000 shares. As of June 30, 2024, there is an aggregate of 182,500 common shares reserved for issuance under the 2020 Plan. All options granted to date have a ten year contractual life and vesting terms of four years. In general, vested options expire if not exercised 90 days after termination of service. A total of 59,727 shares of common stock remained available for future issuance under the 2020 Plan as of August 6, 2024 . Forfeitures are accounted for as they occur. Stock-based compensation expense recognized in selling, general, and administrative, and research and development are as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Options $ 362,748 $ 667,923 $ 1,040,231 $ 1,350,871 Restricted stock 119,052 389,646 287,956 985,807 Stock options - modified options — 11,618 169 24,250 Profit interest units 31,226 34,219 62,452 (291,701) Total $ 513,026 $ 1,103,406 $ 1,390,808 $ 2,069,227 The following is a summary of the stock option activity under the 2010 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 19,115 102.75 3.53 — Granted — — — — Exercised — — — — Forfeited (11) 344.89 — — Expired/Cancelled (53) 54.61 — — Outstanding - June 30, 2024 19,051 102.85 3.01 — Options Exercisable at June 30, 2024 19,044 102.76 3.00 — Options Vested at June 30, 2024 19,044 102.76 3.00 — The weighted-average grant-date fair value of options granted during the six months ended June 30, 2024 was zero. The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 57,892 338.67 7.91 — Granted — — — — Exercised — — — — Forfeited (4,087) 123.89 — — Expired/Cancelled (4,618) 109.54 — — Outstanding - June 30, 2024 49,187 377.73 7.22 — Options Exercisable at June 30, 2024 29,581 501.82 6.89 — Options Vested at June 30, 2024 29,581 501.82 6.89 — The weighted-average grant-date fair value of options granted during the six months ended June 30, 2024 was zero. During the year ended December 31, 2021, 41,000 options were modified to lower the exercise price by $24.00 per share, which resulted in $246,000 of incremental compensation cost to be recognized over the remaining vesting period. The amount of additional compensation expense for the three and six months ended June 30, 2024, was zero and $169, respectively . The amount of additional compensation expense for the three and six months ended June 30, 2023, was $11,618 and $24,250, respectively. Other Information: Six Months Ended 2024 2023 Amount received from option exercised $ — $ — June 30, 2024 Weighted average remaining recognition period Total unrecognized options compensation costs $ 1,810,081 0.82 No amounts relating to the 2010 Plan or 2020 Plan have been capitalized. Compensation cost is recognized over the requisite service period based on the fair value of the options. A summary of the status of the Company’s nonvested restricted stock units as of December 31, 2023, and changes during the six months ended June 30, 2024, is presented below: Shares Weighted- Nonvested at December 31, 2023 10,307 98.03 Granted — — Vested/Release (7,334) 261.14 Cancelled/Forfeited (2,933) 280.13 Nonvested and Outstanding at June 30, 2024 40 1,587.46 As of June 30, 2024, there was $1,851 of total unrecognized compensation cost related to nonvested restricted stock. The Company expects to recognize this compensation cost over a remaining weighted-average period of approximately 0.09 years .

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Income tax expense $ — $ — $ — $ — Effective tax rate 0.0 % 0.0 % 0.0 % 0.0 % The effective tax rate used for interim periods is the estimated annual effective tax rate, based on current estimate of full year results, except that taxes related to specific events, if any, are recorded in the interim period in which they occur. The effective tax rate differed from the U.S. federal statutory tax rate primarily due to operating losses that receive no tax benefit as a result of a valuation allowance recorded for such losses. The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes (“ASC 740”). Under the provisions of ASC 740, management is required to evaluate whether a valuation allowance should be established against its deferred tax assets. The Company currently has a full valuation allowance against its deferred tax assets. As of each reporting date, the Company’s management considers new evidence, both positive and negative, that could impact management’s view with regard to future realization of deferred tax assets. For the six months ended June 30, 2024, there was no material change from the year ended December 31, 2023 in the amount of the Company’s deferred tax assets that are not considered to be more likely than not to be realized in future years.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net loss attributable to Nuvve Holding Corp. common stockholders $ (4,176,717) $ (8,224,707) $ (11,127,626) $ (16,121,858) Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted 6,230,284 693,353 5,172,358 653,245 Net Loss per share attributable to Nuvve common stockholders, basic and diluted $ (0.67) $ (11.86) $ (2.15) $ (24.68) The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Stock options issued and outstanding 72,847 63,074 68,761 62,783 Nonvested restricted stock issued and outstanding 5,176 9,590 40 8,625 Public warrants 71,875 71,875 71,875 71,875 Private warrants 3,406 3,406 3,406 3,406 PIPE warrants 33,844 33,844 33,844 33,844 Stonepeak and Evolve warrants 150,000 150,000 150,000 150,000 Stonepeak and Evolve options 125,000 125,000 125,000 125,000 2022 July Institutional/Accredited Investor Warrants 100,000 100,000 100,000 100,000 2024 February Institutional/Accredited Investor Warrants - series A 4,800,000 — 4,800,000 — 2024 February Institutional/Accredited Investor Warrants - series B 4,500,000 — 4,500,000 — 2024 February Institutional/Accredited Investor Warrants - series C 4,800,000 — 4,800,000 — Total 14,662,149 556,789 14,652,926 555,533

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Parties	Related Parties As described in Note 6 , the Company holds equity interests in and provides certain consulting services to Dreev, an entity in which a stockholder of the Company owns the other portion of Dreev’s equity interests. During the three and six months ended June 30, 2024 the Company recognized re venue of $63,517 and $139,176, respectively, from an entity that is an investor in the Company. During the three and six months ended June 30, 2023, the Company recognized re venue of zero and $65,670, respectively, from an entity that is an investor in the Company. The Company had a balance of accounts receivable of zero at June 30, 2024 and December 31, 2023 from the same entity that is an investor in the Company.

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	Leases The Company has entered into leases for commercial office spaces and vehicles. These leases are not unilaterally cancellable by the Company, are legally enforceable, and specify fixed or minimum amounts. The leases expire at various dates through 2031 and provide for renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties. The leases provide for increases in future minimum annual rental payments based on defined increases in the Consumer Price Index, subject to certain minimum increases. Also, the agreements generally require the Company to pay real estate taxes, insurance, and repairs. Supplemental unaudited condensed consolidated balance sheet information related to leases is as follows: Classification June 30, 2024 December 31, 2023 Operating lease assets Right-of-use operating lease assets $ 4,593,229 4,839,526 Finance lease assets Property, plant and equipment, net 9,925 13,154 Total lease assets $ 4,603,154 $ 4,852,680 Operating lease liabilities - current Operating lease liabilities - current $ 848,497 856,250 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 4,413,069 4,646,383 Finance lease liabilities - current Other liabilities - current 7,170 7,391 Finance lease liabilities - noncurrent Other long-term liabilities 4,621 7,764 Total lease liabilities $ 5,273,357 $ 5,517,788 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Operating lease expense Selling, general and administrative $ 228,633 $ 228,633 $ 457,248 $ 457,267 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,423 1,432 2,547 2,855 Interest on finance lease liabilities Interest income, net 321 464 678 957 Total lease expense $ 230,377 $ 230,529 $ 460,473 $ 461,079 Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2024 June 30, 2024 2024 $ 440,551 $ 3,585 2025 893,046 7,170 2026 921,273 1,793 2027 946,683 — 2028 937,727 — Thereafter 2,860,827 — Total lease payments 7,000,107 12,548 Less: interest (1,738,541) (757) Total lease obligations $ 5,261,566 $ 11,791 Lease term and discount rate: June 30, 2024 December 31, 2023 Weighted-average remaining lease terms (in years): Operating lease 7.4 7.8 Finance lease 1.8 2.5 Weighted-average discount rate: Operating lease 7.8% 7.8% Finance lease 7.8% 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows - operating leases $ 252,997 $ 229,044 Operating cash flows - finance leases $ 3,526 $ 4,686 Financing cash flows - finance leases $ 5,477 $ 4,480 Leased assets obtained in exchange for new finance lease liabilities $ 9,925 $ 15,918 Leased assets obtained in exchange for new operating lease liabilities $ — $ — Sublease In April 2022, the Company entered into a sublease agreement with certain local San Diego companies to sublease a portion of the Company's 4,811 square foot expansion. The term of the sublease is six months to twelve months with fixed base rental income ranging from $2,250 to $14,500 per month. The sublease has no option for renewal or extension at the end of the sublease term. Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Sublease lease income Other, net $ 112,578 $ 101,915 $ 213,379 $ 231,685 Lessor In February 2022, the Company entered into a 10 year master services agreement ("MSA") with a certain school district for FaaS to electrify their school bus fleet. A statement of work (“SOW”) for engineering, procurement and construction ("EPC") was also executed in conjunction with the MSA. As part of this SOW, the Company will provide electric vehicle supply equipment ("EVSE") and related warranties, infrastructure engineering and construction, installation of EVSE, and subscription services to Nuvve’s V2G GIVe platform. The MSA has both lease and non-lease components. The lease component is the EVSE and non-lease components are the EPCs. The Company accounted for the lease components as a sale-type lease with the investment in lease of $106,916 and $112,255 at June 30, 2024 and December 31, 2023, respectively . Lease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Lease income Products and services $ 1,138 $ 24,027 $ 2,276 $ 24,027 Interest income Products and services 4,864 3,835 8,979 6,430 Total lease income $ 6,002 $ 27,862 $ 11,255 $ 30,457
Leases	Leases The Company has entered into leases for commercial office spaces and vehicles. These leases are not unilaterally cancellable by the Company, are legally enforceable, and specify fixed or minimum amounts. The leases expire at various dates through 2031 and provide for renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties. The leases provide for increases in future minimum annual rental payments based on defined increases in the Consumer Price Index, subject to certain minimum increases. Also, the agreements generally require the Company to pay real estate taxes, insurance, and repairs. Supplemental unaudited condensed consolidated balance sheet information related to leases is as follows: Classification June 30, 2024 December 31, 2023 Operating lease assets Right-of-use operating lease assets $ 4,593,229 4,839,526 Finance lease assets Property, plant and equipment, net 9,925 13,154 Total lease assets $ 4,603,154 $ 4,852,680 Operating lease liabilities - current Operating lease liabilities - current $ 848,497 856,250 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 4,413,069 4,646,383 Finance lease liabilities - current Other liabilities - current 7,170 7,391 Finance lease liabilities - noncurrent Other long-term liabilities 4,621 7,764 Total lease liabilities $ 5,273,357 $ 5,517,788 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Operating lease expense Selling, general and administrative $ 228,633 $ 228,633 $ 457,248 $ 457,267 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,423 1,432 2,547 2,855 Interest on finance lease liabilities Interest income, net 321 464 678 957 Total lease expense $ 230,377 $ 230,529 $ 460,473 $ 461,079 Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2024 June 30, 2024 2024 $ 440,551 $ 3,585 2025 893,046 7,170 2026 921,273 1,793 2027 946,683 — 2028 937,727 — Thereafter 2,860,827 — Total lease payments 7,000,107 12,548 Less: interest (1,738,541) (757) Total lease obligations $ 5,261,566 $ 11,791 Lease term and discount rate: June 30, 2024 December 31, 2023 Weighted-average remaining lease terms (in years): Operating lease 7.4 7.8 Finance lease 1.8 2.5 Weighted-average discount rate: Operating lease 7.8% 7.8% Finance lease 7.8% 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows - operating leases $ 252,997 $ 229,044 Operating cash flows - finance leases $ 3,526 $ 4,686 Financing cash flows - finance leases $ 5,477 $ 4,480 Leased assets obtained in exchange for new finance lease liabilities $ 9,925 $ 15,918 Leased assets obtained in exchange for new operating lease liabilities $ — $ — Sublease In April 2022, the Company entered into a sublease agreement with certain local San Diego companies to sublease a portion of the Company's 4,811 square foot expansion. The term of the sublease is six months to twelve months with fixed base rental income ranging from $2,250 to $14,500 per month. The sublease has no option for renewal or extension at the end of the sublease term. Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Sublease lease income Other, net $ 112,578 $ 101,915 $ 213,379 $ 231,685 Lessor In February 2022, the Company entered into a 10 year master services agreement ("MSA") with a certain school district for FaaS to electrify their school bus fleet. A statement of work (“SOW”) for engineering, procurement and construction ("EPC") was also executed in conjunction with the MSA. As part of this SOW, the Company will provide electric vehicle supply equipment ("EVSE") and related warranties, infrastructure engineering and construction, installation of EVSE, and subscription services to Nuvve’s V2G GIVe platform. The MSA has both lease and non-lease components. The lease component is the EVSE and non-lease components are the EPCs. The Company accounted for the lease components as a sale-type lease with the investment in lease of $106,916 and $112,255 at June 30, 2024 and December 31, 2023, respectively . Lease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Lease income Products and services $ 1,138 $ 24,027 $ 2,276 $ 24,027 Interest income Products and services 4,864 3,835 8,979 6,430 Total lease income $ 6,002 $ 27,862 $ 11,255 $ 30,457

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies (a) Legal Matters The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities, including product liability claims. Management believes that any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the financial condition or results of operations of the Company. Please see Note 17(e) and (f) below for details regarding legal proceedings with Company suppliers. (b) Research Agreement Effective September 1, 2016, the Company is party to a research agreement with a third party, which is also a Company stockholder, whereby the third party will perform research activity as specified annually by the Company. Under the terms of the agreement, the Company paid a minimum of $400,000 annually in equal quarterly installments. For the six months ended June 30, 2024 and 2023, $42,714 and $233,333 , respectively, were paid under the research agreement. In September 2023, the agreement was renewed through December 2024. At June 30, 2024, $213,571 remained to be paid under the renewed agreement. (c) In-Licensing The Company is a party to a licensing agreement for non-exclusive rights to intellectual property which will expire at the later of the date at which the last patent underlying the intellectual property expires or 20 years from the sale of the first licensed product. Under the terms of the agreement, the Company will pay up to an aggregate of $700,000 in royalties upon achievement of certain milestones. As of June 30, 2024 and December 31, 2023, no royalty expenses had been incurred under this agreement . In November 2017, the Company executed an agreement ("IP Acquisition Agreement") with the University of Delaware ("Seller") whereby all rights, title, and interest in the licensed intellectual property was assigned to the Company in exchange for an upfront fee of $500,000 and common shares valued at $1,491,556. The total acquisition cost of $1,991,556 was capitalized and is being amortized over the fifteen year expected life of the patents underlying the intellectual property. Under the terms of the agreement, the Company will pay up to an aggregate $7,500,000 in royalties to the Seller upon achievement of milestones, related to the aggregate number of vehicles that have had access to the Company’s GIVe platform system for a period of at least six Milestone Event: Aggregated Vehicles Milestone 10,000 $ 500,000 20,000 750,000 40,000 750,000 60,000 750,000 80,000 750,000 100,000 1,000,000 200,000 1,000,000 250,000 2,000,000 $ 7,500,000 The Seller will retain a non-exclusive, royalty-free license, to utilize the intellectual property solely for research and education purposes. As of June 30, 2024, no royalty expenses had been incurred under this agreement. (d) Investment The Company is committed to possible future additional contributions to the Investment in Dreev ( Note 6 ) in the amount of $270,000. (e) Purchase Commitments On July 20, 2021, Nuvve issued a purchase order (“PO”) to its supplier, Rhombus Energy Solutions, Inc. (“Rhombus”), for a quantity of DC fast chargers and dispensers for EVs (the “DC Chargers”), for a total price of $13.2 million. A dispute (the "Dispute") arose as to the PO, and an arbitration proceeding was initiated. On February 2, 2024 (the “Settlement Date”), the Company and Rhombus entered into a settlement and release agreement (the “Settlement Agreement”) pursuant to which, among other things, the Company agreed to pay Rhombus approximately $0.46 million for certain initial DC Chargers within 15 days from the Settlement Date. The Company further agreed to pay Rhombus an aggregate of $2.40 million for certain DC Chargers upon shipment with payments correlating to the amounts shipped due prior to shipment, a minimum of 50% of which shall be paid within 12 months after the Settlement Date, with the remaining balance, if any, to be paid within 24 months after the Settlement Date. The Settlement Agreement further provides for the dismissal of the legal action as to the Company and Rhombus. The Company and Rhombus agreed to release one another from any and all claims relating to the Dispute. (f) School Bus Storage Litigation In October and November 2021, the Company purchased an aggregate of five school buses from a certain school bus dealership in Pittsburgh, Pennsylvania. Thereafter, the Company entered into agreements to sell these buses to certain third-party purchasers. However, the dealership refused to release four of the buses and to provide us with a manufacturer statement of origin (an “MSO”) for all five buses, claiming that the Company owed them approximately $0.45 million in storage fees allegedly incurred since January 2022. The Company disputed that it had an obligation to pay the storage fees as well as the amount of fees demanded by the dealership, and filed a petition for preliminary injunction with the Court of Common Pleas of Allegheny County, Pennsylvania. On November 1, 2023, the court granted the Company's petition for preliminary injunction requiring the dealership to release and provide keys for the four buses and to provide the MSOs for all five buses, contingent on the Company posting an injunction bond in the amount of $0.55 million within seven days of the order. The Company timely posted the injunction bond on November 7, 2023. The Company anticipates that the storage fee dispute with the dealership will be adjudicated by the end of the fiscal year 2024.

Non-Controlling Interest

Non-Controlling Interest	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest [Abstract]
Non-Controlling Interest	Non-Controlling Interest For entities that are consolidated, but not 100% owned, a portion of the net income or loss and corresponding equity is allocated to owners other than the Company. The aggregate of the net income or loss and corresponding equity that is not owned by the Company is included in non-controlling interests in the condensed consolidated financial statements. Non-controlling interests are presented outside as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheets. The primary components of non-controlling interests are separately presented in the Company’s condensed consolidated statements of changes in stockholders’ equity to clearly distinguish the interest in the Company and other ownership interests in the consolidated entities. Net income or loss includes the net income or loss attributable to the holders of non-controlling interests on the Company’s condensed consolidated statements of operations. Net income or loss is allocated to non-controlling interests in proportion to their relative ownership interests. Levo Series B Redeemable Preferred Stock Levo is authorized to issue 1,000,000 shares of Series B Preferred Stock at no par value. The Series B Preferred Stock (a) pays a dividend, when, as and if declared by Levo's Board of Directors, of 8.0% per annum of the stated value per share, payable quarterly in arrears, (b) has an initial stated value of $1,000 per share, and dividends are paid in cash. Levo accrues for undeclared and unpaid dividends as they are payable in accordance with the terms of the Certificate of Designations filed with the Secretary of State of the State of Delaware. At June 30, 2024, Levo had accumulated unpaid accrued preferred dividends of $763,709, included in accrued liabilities, on 3,138 issued and outstanding shares of Series B Preferred Stock. Series B Preferred Stock is not a participating or convertible securities. Series B Preferred Stock is not currently redeemable but it could be redeemable with the passage of time at the election of Levo or the preferred shareholders or upon the occurrence of a trigger event as defined in the preferred stock agreement. Since the redeemable preferred stock may be redeemed by the preferred shareholders or upon the occurrence of a trigger event that is not solely within the control of Levo, but is not mandatorily redeemable; therefore, based on its characteristics, Levo has classified the Series B Preferred Stock as mezzanine equity. At June 30, 2024, Series B Preferred Stock consisted of the following: Shares Authorized Shares Issued and Outstanding Stated Value per Share Initial Carrying Value Cumulative Unpaid Accrued Preferred Dividends Liquidation Preference 1,000,000 3,138 $ 1,000 $ 3,138,000 $ 763,709 $ 3,901,709 The Company has determined that the redemption features embedded in the non-controlling redeemable preferred stock is required to be accounted for separately from the redeemable preferred stock as a derivative liability. See Note 5 for detail disclosure of the derivative liability. The redeemable preferred stock has been initially recognized at fair value of $3,138,000, the proceeds on the date of issuance. This amount has been further reduced by $497,606, the fair value of the embedded derivative liability at date of issuance, resulting in an adjusted initial value of $2,640,394. Levo is accreting the difference between the adjusted carrying initial value and the redemption price value over the seven-year period from date of issuance of August 4, 2021 through July 4, 2028 (the date at which the preferred shareholders have the unconditional right to redeem the shares, deemed to be the earliest likely redemption date) using the effective interest method. The accretion to the carrying value of the redeemable preferred stock is treated as a deemed dividend, recorded as a charge to retained earnings of Levo. During the six months ended June 30, 2024, Levo accreted $322,932 resulting in the carrying value of the redeemable preferred stock of $4,516,561. The following table summarizes Levo non-controlling interests presented as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheet at June 30, 2024: June 30, 2024 December 31, 2023 Beginning Balance $ (4,894,101) (3,950,186) Net income (loss) attributable to non-controlling interests $ (24,566) (12,456) Less: dividends paid to non-controlling interests 151,508 285,595 Less: Preferred share accretion adjustment 322,932 645,864 Non-controlling interests $ (5,393,107) $ (4,894,101) The following table summarizes Levo non-controlling interests presented as a separate component of the Company’s condensed consolidated statements of operations as of June 30, 2024: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net income (loss) attributable to non-controlling interests $ (10,268) $ 8,466 $ (24,566) $ 14,754 Redeemable Non-controlling Interest Reconciliation — Mezzanine Equity June 30, 2024 December 31, 2023 Beginning balance $ 4,193,629 $ 3,547,765 Preferred share Accretion adjustment 322,932 645,864 Ending balance $ 4,516,561 $ 4,193,629 Profits Interests Units (Class D Incentive Units) In April 2022, Levo issued Class D Incentive Units to certain key employees in the form of profits interests within the meaning of the Internal Revenue Service (“Profits Interests”). Any future distributions under the Profits Interests will only occur once distributions made to all other member units exceed a threshold amount. The Company performed an analysis of the key features of the Profits Interests to determine whether the nature of the Profits Interests are (a) an equity award which should be accounted for under ASC 718, Compensation – Stock Compensation or (b) a bonus arrangement which should be accounted for under ASC 710, Compensation – General . Based on the features of the Profits Interests, the awards are considered stock compensation to be accounted for as equity. Accordingly, compensation expense for the Profits Interests will be recognized over the vesting period of the awards. Subject to the grantee not incurring a termination prior to the applicable vesting date, the Incentive Units will vest as follows: (i) 80% of the Incentive Units will vest in equal 25.0% installments on each of the first four (4) anniversaries of the grant date (such that 80% of the total number of Incentive Units issued to the grantee hereunder will be vested on the fourth anniversary of the Grant Date) and (ii) the remaining 20% of the Incentive Units will vest upon a Change of Control. Therefore, the expenses recorded will only reflect the 80% vesting portion. During the three and six months ended June 30, 2024, the Company recorded compensation expenses, included in selling, general, and administrative, under the Profits Interests of $31,226 and $62,452 , respectively. During the three and six months ended June 30, 2023, the Company recorded compensation expenses, included in selling, general, and administrative, under the Profits Interests of $34,219 and $62,451, respectively. The Company uses the M onte Carlo Simulation model to estimate the fair value of Class D Incentive Units. Fair value is estimated at the date of grant for employee and nonemployee options. The following assumptions were used in the M onte Carlo Simulation model to calculate the fair value of Class D Incentive Units outstanding as of June 30, 2024. Class D Units Expected life of Class D Incentive Units (in years) (1) 5.5 Risk-free interest rate (2) 3.02 % Volatility (3) 69.50 % __________________ (1) The expected life of options is the average of the contractual term of the Class D Incentive Units and the vesting period. (2) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (3) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common Stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry. A summary of the status of the Company’s Class D Incentive Units as of December 31, 2023, and changes during the six months ended June 30, 2024, is presented below: Shares Weighted- Nonvested at December 31, 2023 50,000 12.49 Granted — — Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2024 50,000 12.49 As of June 30, 2024, there was $220,930 of total unrecognized compensation cost related to nonvested Class D Incentive Units. The Company expects to recognize this compensation cost over a remaining weighted-average period of approximately 1.50 years .

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Term Loan On August 9, 2024, the Company entered into a Subordinated Business Loan and Security Agreement ("Term Loan") with Agile Lending, LLC, as lender, and Agile Capital Funding, LLC, as collateral agent. The Term Loan is a short-term, thirty-week, fixed interest rate obligation. Principal and interest on the Term Loan are payable in arrears weekly. The Term Loan is secured by certain Company assets, and it is evidenced by a subordinated secured promissory note. The Term Loan contains customary affirmative and negative covenants. Among other things, these covenants restrict the Company's ability to incur certain types or amounts of indebtedness, incur liens on certain assets, dispose of material assets, enter into certain restrictive agreements, or engage in certain transactions with affiliates. Additionally, the Term Loan contains customary default provisions including, but not limited to, failure to pay interest or principal when due. The foregoing summary of the Term Loan is qualified in its entirety by reference to the text of the agreement. Please refer to Exhibit 10.2 in this Quarterly Report on Form 10-Q for the full text of the agreement. The following is a summary description of the key terms of the Term Loan: Debt Debt Origination Date Maturity Principal Amount Borrowed Carrying Value Weighted Weekly Average Interest Rate Term loan 8/9/2024 3/6/2025 $ 1,000,000 $ 1,000,000 2.96 % Principal and interest payments of $50,750 is due weekly on the Term Loan for thirty weeks effective August 9, 2024 to March 6, 2025, when the Term Loan is fully paid off. Total interest of $522,501 is expected to be paid over the thirty-week loan period.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (3,938,747)	$ (7,992,563)	$ (10,653,186)	$ (15,658,956)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Reverse Stock Split	Reverse Stock Split At the Company’s Special Meeting of Stockholders held on January 5, 2024, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio within the range of 1-for-2 to 1-for-40. The Board approved a 1-for-40 reverse split ratio, and on January 19, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect the reverse split effective January 19, 2024. The reverse stock split is also applicable to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable are adjusted proportionately as a result of the reverse stock spli t. The exercise prices of any outstanding warrants or stock options will also be proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans. The re verse stock split did not affect the number of authorized shares of the Company's common stock or the par value of the common stock. All issued and outstanding common stock, options to purchase common stock, warrants to purchase common stock and per share amounts contained in the condensed consolidated financial statement have been retroactively adjusted to reflect the reverse stock split for all periods presented.
Basis of Presentation	Basis of Presentation The accompanying (i) unaudited condensed consolidated balance sheet as of December 31, 2023, which has been derived from audited financial statements, and (ii) unaudited interim condensed consolidated financial statements have been prepared in accordance pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. Therefore, it is recommended that these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the 2023 Form 10-K, filed with the SEC on March 28, 2024. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, cash flows, and total equity for the interim periods, but are not necessarily indicative of the results to be anticipated for the full year 2024 or any future period. In accordance with the related Going Concern accounting standards, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. Since inception, the Company has incurred recurring losses and negative cash flows from operations and has an accumulated deficit o f $158.9 million and $148.2 million as of June 30, 2024 and December 31, 2023, respectively. The Company incurred operating losses of approximately $13.0 million as of the six months ended June 30, 2024, and $32.1 million and $36.9 million for the years ended December 31, 2023, and 2022, respectively. The Company's cash used in operations were $8.7 million for the six months ended June 30, 2024, and $21.3 million and $34.1 million for the years ended December 31, 2023, and 2022, respectively. As of June 30, 2024, the Company had a cash balance, working capital, and total equity of $1.4 million, $2.6 million and $2.7 million, respectively. The Company continues to expect to generate operating losses and negative cash flows and will need additional funding to support its planned operating activities through profitability. The transition to profitability is dependent upon the successful expanded commercialization of the Company's GIVe platform and the achievement of a level of revenues adequate to support its cost structure. Management plans to fund current operations through increased revenues and raising additional capital. Management's expectations with respect to the Company’s ability to fund current planned operations is based on estimates that are subject to risks and uncertainties. There is an inherent risk that the Company may not achieve such financial projections and if so, cash outflows could be higher than currently anticipated. However, as such, plans are not solely within management’s control, management cannot conclude as of the date of this filing that the plans are probable of being successfully implemented and as such has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for twelve months from the date of issuance of our financial statements. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
Principles of Consolidation	Principles of Consolidation
Variable Interest Entities	Variable Interest Entities Pursuant to the consolidation guidance, the Company first evaluates whether it holds a variable interest in an entity in which it has a financial relationship and, if so, whether or not that entity is a variable interest entity ("VIE"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company formed Levo with Stonepeak and Evolve, in which the Company owns 51% of Levo's common units. The Company has determined that Levo is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates Levo and records a non-controlling interest for the share of the entity owned by Stonepeak and Evolve. Assets and Liabilities of Consolidated VIEs The Company's condensed consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net income (loss) attributable to non-controlling interests" in the condensed consolidated statements of operations and "Non-controlling interests" in the condensed consolidated balance sheets. See Note 18 for details of non-controlling interests. The Company began consolidating the assets, liabilities and results of operations of Levo during the quarter ended September 30, 2021.
Redeemable Non-Controlling Interest - Mezzanine Equity/Non-controlling Interests	Redeemable Non-Controlling Interest - Mezzanine Equity Redeemable non-controlling interest represents the shares of the preferred stock issued by Levo to Stonepeak and Evolve (the "preferred shareholders"), who own 49% of Levo common units. The preferred stock is not mandatorily redeemable or currently redeemable, but it could be redeemable with the passage of time at the election of Levo, the preferred shareholders or a triggering event as defined in the preferred stock agreement. As a result of the contingent put right available to the preferred shareholders, the redeemable non-controlling interests in Levo are classified as mezzanine equity in the Company’s unaudited condensed consolidated balance sheets. The initial carrying value of the redeemable non-controlling interest is reported at the initial proceeds received on issuance date, reduced by the fair value of embedded derivatives resulting in an adjusted initial carrying value. The adjusted initial carrying value is further adjusted for the accretion of the difference with the redemption price value using the effective interest method. The accretion amount is a deemed dividend recorded against retained earnings or, in its absence, to additional paid-in-capital. The carrying amount of the redeemable non-controlling interest is measured at the higher of the carrying amount adjusted each reporting period for income (or loss) attributable to the non-controlling interest, or the carrying amount adjusted each reporting period by the accretion amount. See Note 18 for details. Non-controlling interests The Company presents non-controlling interests as a component of equity on its condensed consolidated balance sheets and reports the portion of its earnings or loss for non-controlling interest as net earnings or loss attributable to non-controlling interests in the condensed consolidated statements of operations. For entities that are consolidated, but not 100% owned, a portion of the net income or loss and corresponding equity is allocated to owners other than the Company. The aggregate of the net income or loss and corresponding equity that is not owned by the Company is included in non-controlling interests in the condensed consolidated financial statements. Non-controlling interests are presented outside as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheets. The primary components of non-controlling interests are separately presented in the Company’s condensed consolidated statements of changes in stockholders’ equity to clearly distinguish the interest in the Company and other ownership interests in the consolidated entities. Net income or loss includes the net income or loss attributable to the holders of non-controlling interests on the Company’s condensed consolidated statements of operations. Net income or loss is allocated to non-controlling interests in proportion to their relative ownership interests.
Emerging Growth Company	Emerging Growth Company
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include the impairment of intangible assets, the net realizable value of inventory, the fair value of share-based payments, lease incremental borrowing rate, derivative liability associated with redeemable preferred shares, revenue recognition, the fair value of warrants, annual bonus accrual, and the recognition and disclosure of contingent liabilities. Management evaluates its estimates on an ongoing basis. Actual results could materially vary from those estimates.
Cash and Restricted Cash	Cash and Restricted Cash The Company maintains cash balances that can, at times, exceed amounts insured by the Federal Deposit Insurance Corporation, which is up to $250,000. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk in this area. In connection with a new office lease agreement, the Company was required to provide an irrevocable, unconditional letter of credit to the landlord upon execution of the lease. The amount securing the letter of credit was recorded as restricted cash as of June 30, 2024 and December 31, 2023 was $480,000 .
Concentrations of Credit Risk	Concentrations of Credit Risk At June 30, 2024 and December 31, 2023, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits) and trade receivables. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the three and six months ended June 30, 2024 three customers accounted for 57.1% and 44.7% of revenue, respectively. For the three and six months ended June 30, 2023 two and one customer accounted for 28.4% and 27.5% o f revenue, respectively. During the three and six months ended June 30, 2024, the Company's top five customers accounted for approximately 75.4% and 62.4% o f the Company’s total revenue, respectively. During the three and six months ended June 30, 2023, the Company's top five customers accounted for approximately 53.5% and 52.1% o f the Company’s total revenue, respectively. At June 30, 2024, three customers accounted for 68.9% of accounts receivable. At December 31, 2023, three customers accounted for 60.9% of a ccounts receivable. Approximat ely 95.0% and 74.0% of the Company’s trade accounts receivable balance was with five customers at June 30, 2024 and December 31, 2023 , respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all probable bad debt losses have been appropriately considered in establishing the allowance for doubtful accounts.
Recently adopted accounting pronouncements/Recently issued accounting pronouncements not yet adopted	Recently adopted accounting pronouncements None Applicable Recently issued accounting pronouncements not yet adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the Company’s CODM. The amendments in this update also provide new segment disclosure requirements for entities with a single reportable segment, and expand the interim segment disclosure requirements. ASU 2023-07 is effective for the fiscal year ending December 31, 2024 and for the Company’s interim periods beginning with the first quarter ended 2025. Early adoption is permitted and the amendments in this update are required to be applied on a retrospective basis. The Company is currently evaluating the impact of this guidance on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures . ASU 2023-09 requires disclosure of disaggregated income taxes paid in both U.S. and foreign jurisdictions, prescribes standard categories for the components of the effective tax rate reconciliation and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company’s fiscal year ending December 31, 2025. Early adoption is permitted and the amendments in this update should be applied on a prospective basis, though retrospective adoption is permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Schedule of assets and liabilities included in the company’s condensed consolidated balance sheets	The following table summarizes the carrying amounts of Levo assets and liabilities included in the Company’s condensed consolidated balance sheets at June 30, 2024 and December 31, 2023: June 30, 2024 December 31, 2023 Assets Cash $ 4,953 $ 27,337 Prepaid expenses and other current assets 341 1,363 Total Assets $ 5,294 $ 28,700 Liabilities Accounts payable $ 24,280 $ 8,380 Accrued expenses and dividend payable 761,329 620,421 Derivative liability - non-controlling redeemable preferred shares 313,354 309,728 Total Liabilities $ 1,098,963 $ 938,529

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of information regarding disaggregated revenue based on revenue by service	The following table provides information regarding disaggregated revenue: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenue recognized over time: Services - engineering and others $ 186,269 $ 409,895 $ 366,500 $ 631,731 Grid services 115,298 92,391 154,938 222,054 Grants 131,421 71,118 214,837 145,519 Revenue recognized at point in time: Products 369,192 1,546,723 845,661 2,975,609 Total revenue $ 802,180 $ 2,120,127 $ 1,581,936 $ 3,974,913
Schedule of aggregate amount of revenue for the Company’s existing contracts with customers	The aggregate amount of revenue for the Company’s existing contracts and grants with customers as of June 30, 2024 expected to be recognized in the future, and classified as deferred revenue on the condensed consolidated balance sheet, for year ended December 31, is as follows (this disclosure does not include revenue related to contracts whose original expected duration is one year or less): 2024 (remaining six months) 386,817 2025 286,168 2026 148,109 2027 113,197 Thereafter 135,687 Total (1) $ 1,069,978 __________________ (1) The revenue recognition is subject to the completion of construction and commissioning of the EV infrastructure.
Schedule of segment revenue and assets	The following table summarizes the Company’s revenues by geography: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenues: United States $ 746,454 $ 1,979,610 $ 1,502,064 $ 3,738,063 United Kingdom — — — 33,483 Denmark 55,726 140,517 79,872 203,367 $ 802,180 $ 2,120,127 $ 1,581,936 $ 3,974,913 The following table summarizes the Company’s intangible assets and property, plant and equipment in different geographic locations: June 30, December 31, Long-lived assets: United States $ 1,649,866 $ 1,741,009 United Kingdom 2,154 2,894 Denmark 190,380 224,564 $ 1,842,400 $ 1,968,467

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of liabilities measured at fair value on the condensed consolidated balance sheet	The following are the liabilities measured at fair value on the condensed consolidated balance sheet at June 30, 2024 and December 31, 2023 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2024 Total Gains (Losses) For The Six Months Ended June 30, 2024 Recurring fair value measurements Private warrants $ — $ — $ — $ — $ — $ — Stonepeak and Evolve unvested warrants $ — $ — $ — $ — $ — $ — 2022 July Institutional/Accredited Investor warrants $ — $ — $ 3 $ 3 $ 3 $ 4,621 2024 February Institutional/Accredited Investor warrants $ — $ — $ 1,484,504 $ 1,484,504 $ 1,584,770 $ 2,307,813 Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 313,354 $ 313,354 $ 7,907 $ (3,626) Total recurring fair value measurements $ — $ — $ 1,797,861 $ 1,797,861 $ 1,592,680 $ 2,308,808 Level 1: Level 2: Level 3: Total at December 31, Total Gains (Losses) For The Three Months Ended June 30, 2023 Total Gains (Losses) For The Six Months Ended June 30, 2023 Recurring fair value measurements Private warrants $ — $ — $ — $ — $ 784 $ 1,784 Stonepeak and Evolve unvested warrants $ — $ — $ — $ — — — 2022 July Institutional/Accredited Investor warrants $ — $ — $ 4,621 $ 4,621 $ 143,010 $ (71,748) Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 309,728 $ 309,728 $ 83,059 $ 6,219 Total recurring fair value measurements $ — $ — $ 314,349 $ 314,349 $ 226,853 $ (63,745)
Schedule of fair value on a recurring basis	The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11 ) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2024: Private warrants Stonepeak and Evolve unvested warrants 2022 July Institutional/Accredited Investor warrants 2024 February Institutional/Accredited Investor warrants Non-controlling redeemable preferred shares - derivative liability Balance at December 31, 2023 $ — $ — $ 4,621 $ — $ 309,728 Initial fair value — — — 3,792,317 — Total (gains) losses for period included in earnings — — (4,619) (723,043) 11,533 Balance at March 31, 2024 — — 3 3,069,274 321,261 Total (gains) losses for period included in earnings — — (3) (1,584,770) (7,907) Balance at June 30, 2024 $ — $ — $ — $ 1,484,504 $ 313,354
Schedule of fair value measurement inputs and valuation techniques	The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2024: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Capital expenditure forecast (in millions) $— $— $— $— Probability of warrants vesting (a) —% —% —% —% __________________ (a) During the second quarter ended June 30, 2022, the Company significantly lowered its forecast of Levo's capital deployments due to the passage by the United States Congress of the Infrastructure Investment and Jobs Act bill, and the related unveiling of the Environmental Protection Agency’s 2022 Clean School Bus rebates. The resulting lower forecast of capital deployments reduced the probabilities of the future vesting of the unvested warrants. Therefore, at June 30, 2024, the Company has determined that it is unlikely that the unvested warrants will vest. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at December 31, 2023: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Capital expenditure forecast (in millions) $— $— $— $— Probability of warrants vesting (a) —% —% —% —% __________________

Derivative Liability - Non-Co_2

Derivative Liability - Non-Controlling Redeemable Preferred Stock (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of derivative liabilities at fair value	The following table displays the fair value of derivatives by balance sheet line item: June 30, 2024 December 31, 2023 Derivative liability - non-controlling redeemable preferred shares $ 313,354 $ 309,728

Account Receivables, Net (Table

Account Receivables, Net (Tables)	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Schedule of accounts receivable	The following tables summarizes the Company's accounts receivable: June 30, 2024 December 31, 2023 Trade receivables $ 831,909 $ 2,107,497 Less: allowance for credit losses (315,716) (382,598) Accounts receivable, net $ 516,193 $ 1,724,899 Allowance for credit losses: Balance December 31, 2023 $ (382,598) Provision (41,175) Write-off — Recoveries 108,057 Balance at June 30, 2024 $ (315,716)

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Schedule of inventory by category	The following table summarizes the Company’s inventories balance by category: June 30, 2024 December 31, 2023 DC Chargers $ 5,357,368 $ 5,275,934 AC Chargers 446,357 236,316 Component parts and Carbon Credit 240,411 377,203 Total $ 6,044,136 $ 5,889,453

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	The following table summarizes the Company’s property, plant and equipment balance: Useful Lives June 30, 2024 December 31, 2023 Computers & Servers 1 year to 3 years $ 169,528 $ 154,337 Vehicles 5 years to 7 years 65,492 65,577 Office furniture and equipment 3 years to 5 years 366,323 366,323 Test units and loaned chargers (1) 5 years to 7 years 628,032 598,820 Total 1,229,375 1,185,057 Less: Accumulated Depreciation (519,459) (418,793) Property, plant and equipment, net $ 709,916 $ 766,264 Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Depreciation expense $ 51,088 $ 46,571 $ 102,884 $ 96,529 __________________

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of estimated future amortization expense amortizable intangible assets	Total estimated future amortization expense is as follows: 2024 (remaining six months) $ 69,717 2025 139,437 2026 137,770 2027 132,770 2028 132,770 Thereafter 520,019 $ 1,132,483

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Tables)	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Schedule of common stock issuable upon exercise of warrants outstanding	The following table is a summary of the number of shares of the Company’s Common Stock issuable upon exercise of warrants outstanding at June 30, 2024: Number of Number of Number of Exercise Expiration Public Warrants 71,875 — 71,875 $460.00 March 19, 2026 Private Warrants 3,406 — 3,406 $460.00 March 19, 2026 PIPE Warrants 33,844 — 33,844 $460.00 March 19, 2026 Stonepeak/Evolve Warrants - series B 50,000 — 50,000 $400.00 May 17, 2031 Stonepeak/Evolve Warrants - series C 25,000 — 12,500 $600.00 May 17, 2031 Stonepeak/Evolve Warrants - series D 25,000 — 12,500 $800.00 May 17, 2031 Stonepeak/Evolve Warrants - series E 25,000 — 12,500 $1,200.00 May 17, 2031 Stonepeak/Evolve Warrants - series F 25,000 — 12,500 $1,600.00 May 17, 2031 2022 July Institutional/Accredited Investor Warrants 100,000 — 100,000 $150.00 January 29, 2028 2024 February Institutional/Accredited Investor Pre-Funded Warrants 575,000 575,000 — $0.0001 February 2, 2029 2024 February Institutional/Accredited Investor Warrants - series A 4,800,000 — 4,800,000 $2.00 February 2, 2029 2024 February Institutional/Accredited Investor Warrants - series B 4,800,000 300,000 4,500,000 $2.00 November 2, 2024 2024 February Institutional/Accredited Investor Warrants - series C 4,800,000 — 4,800,000 $2.00 February 2, 2029 15,334,125 875,000 14,409,125

Stock Option Plan (Tables)

Stock Option Plan (Tables)	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of stock-based compensation expense for stock options	Stock-based compensation expense recognized in selling, general, and administrative, and research and development are as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Options $ 362,748 $ 667,923 $ 1,040,231 $ 1,350,871 Restricted stock 119,052 389,646 287,956 985,807 Stock options - modified options — 11,618 169 24,250 Profit interest units 31,226 34,219 62,452 (291,701) Total $ 513,026 $ 1,103,406 $ 1,390,808 $ 2,069,227
Schedule of stock option activity	The following is a summary of the stock option activity under the 2010 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 19,115 102.75 3.53 — Granted — — — — Exercised — — — — Forfeited (11) 344.89 — — Expired/Cancelled (53) 54.61 — — Outstanding - June 30, 2024 19,051 102.85 3.01 — Options Exercisable at June 30, 2024 19,044 102.76 3.00 — Options Vested at June 30, 2024 19,044 102.76 3.00 — The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 57,892 338.67 7.91 — Granted — — — — Exercised — — — — Forfeited (4,087) 123.89 — — Expired/Cancelled (4,618) 109.54 — — Outstanding - June 30, 2024 49,187 377.73 7.22 — Options Exercisable at June 30, 2024 29,581 501.82 6.89 — Options Vested at June 30, 2024 29,581 501.82 6.89 — A summary of the status of the Company’s Class D Incentive Units as of December 31, 2023, and changes during the six months ended June 30, 2024, is presented below: Shares Weighted- Nonvested at December 31, 2023 50,000 12.49 Granted — — Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2024 50,000 12.49
Schedule of disclosure of share-based compensation arrangements by share-based payment award	Other Information: Six Months Ended 2024 2023 Amount received from option exercised $ — $ — June 30, 2024 Weighted average remaining recognition period Total unrecognized options compensation costs $ 1,810,081 0.82
Schedule of nonvested restricted stock units	A summary of the status of the Company’s nonvested restricted stock units as of December 31, 2023, and changes during the six months ended June 30, 2024, is presented below: Shares Weighted- Nonvested at December 31, 2023 10,307 98.03 Granted — — Vested/Release (7,334) 261.14 Cancelled/Forfeited (2,933) 280.13 Nonvested and Outstanding at June 30, 2024 40 1,587.46

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of income tax information	Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Income tax expense $ — $ — $ — $ — Effective tax rate 0.0 % 0.0 % 0.0 % 0.0 %

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net loss attributable to Nuvve Holding Corp. common stockholders $ (4,176,717) $ (8,224,707) $ (11,127,626) $ (16,121,858) Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted 6,230,284 693,353 5,172,358 653,245 Net Loss per share attributable to Nuvve common stockholders, basic and diluted $ (0.67) $ (11.86) $ (2.15) $ (24.68)
Schedule of antidilutive securities excluded from the computation of earnings per share	The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Stock options issued and outstanding 72,847 63,074 68,761 62,783 Nonvested restricted stock issued and outstanding 5,176 9,590 40 8,625 Public warrants 71,875 71,875 71,875 71,875 Private warrants 3,406 3,406 3,406 3,406 PIPE warrants 33,844 33,844 33,844 33,844 Stonepeak and Evolve warrants 150,000 150,000 150,000 150,000 Stonepeak and Evolve options 125,000 125,000 125,000 125,000 2022 July Institutional/Accredited Investor Warrants 100,000 100,000 100,000 100,000 2024 February Institutional/Accredited Investor Warrants - series A 4,800,000 — 4,800,000 — 2024 February Institutional/Accredited Investor Warrants - series B 4,500,000 — 4,500,000 — 2024 February Institutional/Accredited Investor Warrants - series C 4,800,000 — 4,800,000 — Total 14,662,149 556,789 14,652,926 555,533

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Schedule of lease costs	Supplemental unaudited condensed consolidated balance sheet information related to leases is as follows: Classification June 30, 2024 December 31, 2023 Operating lease assets Right-of-use operating lease assets $ 4,593,229 4,839,526 Finance lease assets Property, plant and equipment, net 9,925 13,154 Total lease assets $ 4,603,154 $ 4,852,680 Operating lease liabilities - current Operating lease liabilities - current $ 848,497 856,250 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 4,413,069 4,646,383 Finance lease liabilities - current Other liabilities - current 7,170 7,391 Finance lease liabilities - noncurrent Other long-term liabilities 4,621 7,764 Total lease liabilities $ 5,273,357 $ 5,517,788 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Operating lease expense Selling, general and administrative $ 228,633 $ 228,633 $ 457,248 $ 457,267 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,423 1,432 2,547 2,855 Interest on finance lease liabilities Interest income, net 321 464 678 957 Total lease expense $ 230,377 $ 230,529 $ 460,473 $ 461,079 Lease term and discount rate: June 30, 2024 December 31, 2023 Weighted-average remaining lease terms (in years): Operating lease 7.4 7.8 Finance lease 1.8 2.5 Weighted-average discount rate: Operating lease 7.8% 7.8% Finance lease 7.8% 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows - operating leases $ 252,997 $ 229,044 Operating cash flows - finance leases $ 3,526 $ 4,686 Financing cash flows - finance leases $ 5,477 $ 4,480 Leased assets obtained in exchange for new finance lease liabilities $ 9,925 $ 15,918 Leased assets obtained in exchange for new operating lease liabilities $ — $ —
Schedule of lessee, operating lease, liability, maturity	Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2024 June 30, 2024 2024 $ 440,551 $ 3,585 2025 893,046 7,170 2026 921,273 1,793 2027 946,683 — 2028 937,727 — Thereafter 2,860,827 — Total lease payments 7,000,107 12,548 Less: interest (1,738,541) (757) Total lease obligations $ 5,261,566 $ 11,791
Schedule of finance lease, liability, maturity	Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2024 June 30, 2024 2024 $ 440,551 $ 3,585 2025 893,046 7,170 2026 921,273 1,793 2027 946,683 — 2028 937,727 — Thereafter 2,860,827 — Total lease payments 7,000,107 12,548 Less: interest (1,738,541) (757) Total lease obligations $ 5,261,566 $ 11,791
Schedule of sublease income	Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Sublease lease income Other, net $ 112,578 $ 101,915 $ 213,379 $ 231,685
Schedule of lease income	Lease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2024 2023 2024 2023 Lease income Products and services $ 1,138 $ 24,027 $ 2,276 $ 24,027 Interest income Products and services 4,864 3,835 8,979 6,430 Total lease income $ 6,002 $ 27,862 $ 11,255 $ 30,457

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of milestone event	Under the terms of the agreement, the Company will pay up to an aggregate $7,500,000 in royalties to the Seller upon achievement of milestones, related to the aggregate number of vehicles that have had access to the Company’s GIVe platform system for a period of at least six Milestone Event: Aggregated Vehicles Milestone 10,000 $ 500,000 20,000 750,000 40,000 750,000 60,000 750,000 80,000 750,000 100,000 1,000,000 200,000 1,000,000 250,000 2,000,000 $ 7,500,000

Non-Controlling Interest (Table

Non-Controlling Interest (Tables)	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest [Abstract]
Schedule of preferred stock	At June 30, 2024, Series B Preferred Stock consisted of the following: Shares Authorized Shares Issued and Outstanding Stated Value per Share Initial Carrying Value Cumulative Unpaid Accrued Preferred Dividends Liquidation Preference 1,000,000 3,138 $ 1,000 $ 3,138,000 $ 763,709 $ 3,901,709
Schedule of condensed financial statements	The following table summarizes Levo non-controlling interests presented as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheet at June 30, 2024: June 30, 2024 December 31, 2023 Beginning Balance $ (4,894,101) (3,950,186) Net income (loss) attributable to non-controlling interests $ (24,566) (12,456) Less: dividends paid to non-controlling interests 151,508 285,595 Less: Preferred share accretion adjustment 322,932 645,864 Non-controlling interests $ (5,393,107) $ (4,894,101)
Schedule of condensed income statement	The following table summarizes Levo non-controlling interests presented as a separate component of the Company’s condensed consolidated statements of operations as of June 30, 2024: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net income (loss) attributable to non-controlling interests $ (10,268) $ 8,466 $ (24,566) $ 14,754
Schedule of redeemable noncontrolling interest	Redeemable Non-controlling Interest Reconciliation — Mezzanine Equity June 30, 2024 December 31, 2023 Beginning balance $ 4,193,629 $ 3,547,765 Preferred share Accretion adjustment 322,932 645,864 Ending balance $ 4,516,561 $ 4,193,629
Schedule of black-scholes option pricing model to estimate the fair value of stock options	The following assumptions were used in the M onte Carlo Simulation model to calculate the fair value of Class D Incentive Units outstanding as of June 30, 2024. Class D Units Expected life of Class D Incentive Units (in years) (1) 5.5 Risk-free interest rate (2) 3.02 % Volatility (3) 69.50 % __________________ (1) The expected life of options is the average of the contractual term of the Class D Incentive Units and the vesting period. (2) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (3) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common Stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry.
Schedule of stock option activity	The following is a summary of the stock option activity under the 2010 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 19,115 102.75 3.53 — Granted — — — — Exercised — — — — Forfeited (11) 344.89 — — Expired/Cancelled (53) 54.61 — — Outstanding - June 30, 2024 19,051 102.85 3.01 — Options Exercisable at June 30, 2024 19,044 102.76 3.00 — Options Vested at June 30, 2024 19,044 102.76 3.00 — The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2024: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2023 57,892 338.67 7.91 — Granted — — — — Exercised — — — — Forfeited (4,087) 123.89 — — Expired/Cancelled (4,618) 109.54 — — Outstanding - June 30, 2024 49,187 377.73 7.22 — Options Exercisable at June 30, 2024 29,581 501.82 6.89 — Options Vested at June 30, 2024 29,581 501.82 6.89 — A summary of the status of the Company’s Class D Incentive Units as of December 31, 2023, and changes during the six months ended June 30, 2024, is presented below: Shares Weighted- Nonvested at December 31, 2023 50,000 12.49 Granted — — Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2024 50,000 12.49

Subsequent Events (Tables)

Subsequent Events (Tables)	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Schedule of Short-Term Debt	The following is a summary description of the key terms of the Term Loan: Debt Debt Origination Date Maturity Principal Amount Borrowed Carrying Value Weighted Weekly Average Interest Rate Term loan 8/9/2024 3/6/2025 $ 1,000,000 $ 1,000,000 2.96 %

Organization and Description _2

Organization and Description of Business (Details)	Jan. 19, 2024	Jun. 30, 2024 subsidiary
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Stock conversion ratio	0.5
Minimum
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Stock conversion ratio	0.025
Maximum
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Stock conversion ratio	0.025
Nuvve
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of wholly owned subsidiaries		2
Nuvve Corp.
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of wholly owned subsidiaries		4

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Accumulated deficit	$ 158,894,045		$ 158,894,045		$ 148,240,859
Operating loss	5,763,874	$ 8,315,540	13,011,249	$ 16,193,770	32,100,000	$ 36,900,000
Net cash used in operating activities			8,736,566	$ 9,048,111	21,300,000	$ 34,100,000
Cash	1,431,414		1,431,414		1,534,660
Working capital	2,600,000		2,600,000
Stockholders’ equity	2,732,752		2,732,752		6,990,463
Restricted cash	$ 480,000		$ 480,000		480,000
Levo Mobility LLC | Stonepeak
Summary of Significant Accounting Policies [Line Items]
Stonepeak and Evolve ownership (percent)	49%		49%
Variable Interest Entity | Levo Mobility LLC
Summary of Significant Accounting Policies [Line Items]
Cash	$ 4,953		$ 4,953		$ 27,337
Variable interest entity			51%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Assets and liabilities of consolidated VIEs (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Assets
Cash	$ 1,431,414	$ 1,534,660
Total assets	18,527,025	20,950,506
Liabilities
Accounts payable	1,869,527	1,694,325
Accrued expenses and dividend payable	4,920,770	4,632,101
Derivative liability - non-controlling redeemable preferred shares	313,354	309,728
Total liabilities	15,794,273	13,960,043
Variable Interest Entity | Levo Mobility LLC
Assets
Cash	4,953	27,337
Prepaid expenses and other current assets	341	1,363
Total assets	5,294	28,700
Liabilities
Accounts payable	24,280	8,380
Accrued expenses and dividend payable	761,329	620,421
Derivative liability - non-controlling redeemable preferred shares	313,354	309,728
Total liabilities	$ 1,098,963	$ 938,529

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Concentrations of Credit Risk (Details) - Customer Concentration Risk	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenue Benchmark | Three Customers
Revenue, Major Customer [Line Items]
Concentration risk	57.10%		44.70%
Revenue Benchmark | Two Customers
Revenue, Major Customer [Line Items]
Concentration risk		28.40%
Revenue Benchmark | One Customer
Revenue, Major Customer [Line Items]
Concentration risk				27.50%
Revenue Benchmark | Top Five Customers
Revenue, Major Customer [Line Items]
Concentration risk	75.40%	53.50%	62.40%	52.10%
Accounts Receivable | Three Customers
Revenue, Major Customer [Line Items]
Concentration risk			68.90%		60.90%
Accounts Receivable | Five Customers
Revenue, Major Customer [Line Items]
Concentration risk			95%		74%

Revenue Recognition - Schedule

Revenue Recognition - Schedule of information regarding disaggregated revenue based on revenue by service (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 802,180	$ 2,120,127	$ 1,581,936	$ 3,974,913
Services - engineering and others
Deferred Revenue Arrangement [Line Items]
Total revenue	186,269	409,895	366,500	631,731
Grid services
Deferred Revenue Arrangement [Line Items]
Total revenue	115,298	92,391	154,938	222,054
Grants
Deferred Revenue Arrangement [Line Items]
Total revenue	131,421	71,118	214,837	145,519
Products
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 369,192	$ 1,546,723	$ 845,661	$ 2,975,609

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of aggregate amount of revenue for the Company’s existing contracts with customers (Details)	Jun. 30, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 1,069,978
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 386,817
Revenue, remaining performance obligation, expected timing of satisfaction, period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 286,168
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 148,109
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 113,197
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 135,687
Revenue, remaining performance obligation, expected timing of satisfaction, period

Revenue Recognition - Schedul_3

Revenue Recognition - Schedule of segment activity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Revenues	$ 802,180	$ 2,120,127	$ 1,581,936	$ 3,974,913
United States
Segment Reporting Information [Line Items]
Revenues	746,454	1,979,610	1,502,064	3,738,063
United Kingdom
Segment Reporting Information [Line Items]
Revenues	0	0	0	33,483
Denmark
Segment Reporting Information [Line Items]
Revenues	$ 55,726	$ 140,517	$ 79,872	$ 203,367

Revenue Recognition - Geographi

Revenue Recognition - Geographic Schedule of Intangible Assets, Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 1,842,400	$ 1,968,467
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	1,649,866	1,741,009
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	2,154	2,894
Denmark
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 190,380	$ 224,564

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of liabilities measured at fair value on the condensed consolidated balance sheet (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Recurring fair value measurements
Total recurring fair value measurements	$ 1,797,861		$ 1,797,861		$ 314,349
Recurring fair value measurements, gains (losses) during period	1,592,680		2,308,808	$ (63,745)	226,853
Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	313,354		313,354		309,728
Recurring fair value measurements, gains (losses) during period	7,907		(3,626)	6,219	83,059
Private warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Recurring fair value measurements, gains (losses) during period	0	$ 784	0	1,784
Stonepeak and Evolve unvested warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Recurring fair value measurements, gains (losses) during period	0		0	0	0
2022 July Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	3		3		4,621
Recurring fair value measurements, gains (losses) during period	3		4,621	$ (71,748)	143,010
2024 February Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	1,484,504		1,484,504
Recurring fair value measurements, gains (losses) during period	1,584,770		2,307,813
Level 1: Quoted Prices in Active Markets for Identical Assets
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 1: Quoted Prices in Active Markets for Identical Assets | Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 1: Quoted Prices in Active Markets for Identical Assets | Private warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 1: Quoted Prices in Active Markets for Identical Assets | Stonepeak and Evolve unvested warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 1: Quoted Prices in Active Markets for Identical Assets | 2022 July Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 1: Quoted Prices in Active Markets for Identical Assets | 2024 February Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0
Level 2: Significant Other Observable Inputs
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 2: Significant Other Observable Inputs | Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 2: Significant Other Observable Inputs | Private warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 2: Significant Other Observable Inputs | Stonepeak and Evolve unvested warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 2: Significant Other Observable Inputs | 2022 July Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 2: Significant Other Observable Inputs | 2024 February Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0
Level 3: Significant Unobservable Inputs
Recurring fair value measurements
Total recurring fair value measurements	1,797,861		1,797,861		314,349
Level 3: Significant Unobservable Inputs | Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	313,354		313,354		309,728
Level 3: Significant Unobservable Inputs | Private warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 3: Significant Unobservable Inputs | Stonepeak and Evolve unvested warrants
Recurring fair value measurements
Total recurring fair value measurements	0		0		0
Level 3: Significant Unobservable Inputs | 2022 July Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	3		3		$ 4,621
Level 3: Significant Unobservable Inputs | 2024 February Institutional/Accredited Investor warrants
Recurring fair value measurements
Total recurring fair value measurements	$ 1,484,504		$ 1,484,504

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of fair value on a recurring basis (Details) - USD ($)	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024
Non-controlling redeemable preferred shares - derivative liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	$ 321,261	$ 309,728
Initial fair value		0
Total (gains) losses for period included in earnings	(7,907)	11,533
Balance	313,354	321,261
Private warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	0	0
Initial fair value		0
Total (gains) losses for period included in earnings	0	0
Balance	0	0
Stonepeak and Evolve unvested warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	0	0
Initial fair value		0
Total (gains) losses for period included in earnings	0	0
Balance	0	0
2022 July Institutional/Accredited Investor warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	3	4,621
Initial fair value		0
Total (gains) losses for period included in earnings	(3)	(4,619)
Balance	0	3
2024 February Institutional/Accredited Investor warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	3,069,274	0
Initial fair value		3,792,317
Total (gains) losses for period included in earnings	(1,584,770)	(723,043)
Balance	$ 1,484,504	$ 3,069,274

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details)	Jun. 30, 2024 $ / shares	Dec. 31, 2023 $ / shares	May 17, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term			10 years
Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share)	$ 460
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivatives, term	1 month 2 days	7 months 6 days
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivatives, term	7 years	7 years
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.044	0.039
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	1.010	0.790
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Probability Of Redemption Trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.750	0.750
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	1 year 8 months 19 days	2 years 2 months 19 days
Exercise price (in Dollars per share)	$ 460	$ 460
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Private Warrants | Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.0482	0.0420
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Private Warrants | Measurement Input, Expected Dividend Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Private Warrants | Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.460	0.600
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2022 July Institutional/Accredited Investor warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	3 years 7 months 6 days	4 years 1 month 6 days
Exercise price (in Dollars per share)	$ 150	$ 150
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2022 July Institutional/Accredited Investor warrants | Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.0447	0.0392
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2022 July Institutional/Accredited Investor warrants | Measurement Input, Expected Dividend Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2022 July Institutional/Accredited Investor warrants | Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.570	0.630
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2022 July Institutional/Accredited Investor warrants | Measurement Input, Common Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share)	$ 0.80	$ 0.12
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2024 February Institutional/Accredited Investor warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	4 years 7 months 6 days
Exercise price (in Dollars per share)	$ 2
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2024 February Institutional/Accredited Investor warrants | Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.0437
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2024 February Institutional/Accredited Investor warrants | Measurement Input, Expected Dividend Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2024 February Institutional/Accredited Investor warrants | Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.990
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | 2024 February Institutional/Accredited Investor warrants | Measurement Input, Common Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share)	$ 0.80

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Techniques (Details)	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	May 17, 2021 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 1,797,861	$ 314,349
Series C Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)			$ 5,600,000
Series D Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)			4,800,000
Series E Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)			3,800,000
Series F Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)			$ 3,200,000
Level 3: Significant Unobservable Inputs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	1,797,861	314,349
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series C Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	0	0
Capital expenditure forecast (in millions)	$ 0	$ 0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series C Unvested Warrants | Measurement input, probability of warrants vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of warrants vesting	0	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series D Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 0
Capital expenditure forecast (in millions)	$ 0	$ 0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series D Unvested Warrants | Measurement input, probability of warrants vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of warrants vesting	0	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series E Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 0
Capital expenditure forecast (in millions)	$ 0	$ 0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series E Unvested Warrants | Measurement input, probability of warrants vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of warrants vesting	0	0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series F Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 0
Capital expenditure forecast (in millions)	$ 0	$ 0
Level 3: Significant Unobservable Inputs | Fair Value, Nonrecurring | Series F Unvested Warrants | Measurement input, probability of warrants vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Probability of warrants vesting	0	0

Derivative Liability - Non-Co_3

Derivative Liability - Non-Controlling Redeemable Preferred Stock (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Embedded Derivative [Line Items]
Derivative liability - non-controlling redeemable preferred shares	$ 313,354	$ 309,728
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Change in fair value of derivative liability
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants, Change in fair value of derivative liability
Other Long-term Liabilities
Embedded Derivative [Line Items]
Derivative liability - non-controlling redeemable preferred shares	$ 313,354	$ 309,728

Investments (Details)

Investments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Schedule of Equity Method Investments [Line Items]
Consulting services (in Dollars)	$ 0	$ 0	$ 0	$ 0
Dreev
Schedule of Equity Method Investments [Line Items]
Company's equity ownership	13%		13%

Account Receivables, Net (Detai

Account Receivables, Net (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less: allowance for credit losses	$ (315,716)	$ (382,598)
Accounts receivable, net	516,193	1,724,899
Allowance for credit losses:
Balance December 31, 2023	(382,598)
Provision	(41,175)
Write-off	0
Recoveries	108,057
Balance at June 30, 2024	(315,716)
Trade receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade receivables	$ 831,909	$ 2,107,497

Inventories (Details)

Inventories (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Inventory [Line Items]
Inventory, gross	$ 6,044,136	$ 5,889,453
DC Chargers
Inventory [Line Items]
Inventory, gross	5,357,368	5,275,934
AC Chargers
Inventory [Line Items]
Inventory, gross	446,357	236,316
Component parts and Carbon Credit
Inventory [Line Items]
Inventory, gross	$ 240,411	$ 377,203

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,229,375		$ 1,229,375		$ 1,185,057
Less: Accumulated Depreciation	(519,459)		(519,459)		(418,793)
Property, plant and equipment, net	709,916		709,916		766,264
Depreciation expense	51,088	$ 46,571	102,884	$ 96,529
Computers & Servers
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 169,528		$ 169,528		154,337
Computers & Servers | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	1 year		1 year
Computers & Servers | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	3 years		3 years
Vehicles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 65,492		$ 65,492		65,577
Vehicles | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	5 years		5 years
Vehicles | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	7 years		7 years
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 366,323		$ 366,323		366,323
Office furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years		3 years
Office furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	5 years		5 years
Test units and loaned chargers
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 628,032		$ 628,032		$ 598,820
Test units and loaned chargers | Minimum
Property, Plant and Equipment [Line Items]
Useful lives	5 years		5 years
Test units and loaned chargers | Maximum
Property, Plant and Equipment [Line Items]
Useful lives	7 years		7 years

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Gross intangible asset	$ 2,091,556		$ 2,091,556		$ 2,091,556
Amortization expense of intangible assets	34,860	$ 34,860	69,719	$ 69,719
Finite-lived intangible assets, accumulated amortization	959,072		959,072		$ 889,353
Finite-lived intangible assets, net	$ 1,132,483		$ 1,132,483
Acquire finite-lived intangible assets, weighted average useful life			8 years 3 months 18 days

Intangible Assets - Schedule of

Intangible Assets - Schedule of estimated future amortization expense amortizable intangible assets (Details)	Jun. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining six months)	$ 69,717
2025	139,437
2026	137,770
2027	132,770
2028	132,770
Thereafter	520,019
Total estimated future amortization expense	$ 1,132,483

Stockholders_ Equity (Deficit_2

Stockholders’ Equity (Deficit) (Details)							6 Months Ended
	Feb. 02, 2024 USD ($)	Jan. 31, 2024 $ / shares shares	Jan. 19, 2024	May 17, 2021 USD ($) $ / shares shares	Nov. 11, 2020 USD ($) $ / shares shares	Feb. 19, 2020 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) class_of_stock $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares
Stockholders' Equity [Line Items]
Stock conversion ratio			0.5
Number of classes of stock | class_of_stock							2
Authorized capital stock (in Shares)							101,000,000
Common stock, shares authorized							100,000,000	100,000,000
Common stock par value (in Dollars per share) | $ / shares							$ 0.0001	$ 0.0001
Preferred stock, shares authorized							1,000,000
Preferred stock par value (in Dollars per share) | $ / shares							$ 0.0001
Warrants outstanding, term				10 years
Number of Warrants Exercisable (in shares)							14,409,125
Total recurring fair value measurements | $							$ 1,797,861	$ 314,349
Purchase agreement, authorized amount | $				$ 250,000,000
Sale price (in Dollars per share) | $ / shares				$ 2,000
Grant date fair value of securities purchase agreement | $				$ 12,600,000
Minimum
Stockholders' Equity [Line Items]
Stock conversion ratio			0.025
Maximum
Stockholders' Equity [Line Items]
Stock conversion ratio			0.025
Unit Purchase Option
Stockholders' Equity [Line Items]
Shares issued (in Dollars per share) | $ / shares						$ 100
Exercisable units (in shares)						7,906
Options exercisable (in Dollars per share) | $ / shares						$ 460
Aggregate exercise price | $						$ 3,636,875
Number of shares included in a unit (in shares)						1.1
Unit Purchase Option | Minimum
Stockholders' Equity [Line Items]
Right to registration, period						5 years
Unit Purchase Option | Maximum
Stockholders' Equity [Line Items]
Right to registration, period						7 years
Investor
Stockholders' Equity [Line Items]
Common stock shares purchase (in Shares)					35,625
Stonepeak/Evolve Warrants - series B
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares				$ 400
Number of securities called by warrants (in shares)				50,000
Stonepeak/Evolve Warrants - series C
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares				$ 600
Number of securities called by warrants (in shares)				25,000
Percent of warrants vested upon issuance				50%
Percent of warrants vested upon additional capital expenditures				50%
Additional capital expenditure to trigger exercise of nonvested warrants | $				$ 125,000,000
Stonepeak/Evolve Warrants - series D
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares				$ 800
Number of securities called by warrants (in shares)				25,000
Percent of warrants vested upon issuance				50%
Percent of warrants vested upon additional capital expenditures				50%
Additional capital expenditure to trigger exercise of nonvested warrants | $				$ 250,000,000
Stonepeak/Evolve Warrants - series E
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares				$ 1,200
Number of securities called by warrants (in shares)				25,000
Percent of warrants vested upon issuance				50%
Percent of warrants vested upon additional capital expenditures				50%
Additional capital expenditure to trigger exercise of nonvested warrants | $				$ 375,000,000
Stonepeak/Evolve Warrants - series F
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares				$ 1,600
Number of securities called by warrants (in shares)				25,000
Percent of warrants vested upon issuance				50%
Percent of warrants vested upon additional capital expenditures				50%
Additional capital expenditure to trigger exercise of nonvested warrants | $				$ 500,000,000
Option vesting period				180 days
PIPE warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)					1.9
Sale price (in Dollars per share) | $ / shares					$ 460
Percent of one share of common stock						50%
Stonepeak
Stockholders' Equity [Line Items]
Percent of warrants issued				90%
Evolve
Stockholders' Equity [Line Items]
Percent of warrants issued				10%
Newborn
Stockholders' Equity [Line Items]
Amount of purchase | $					$ 14,250,000
Newborn | Investor
Stockholders' Equity [Line Items]
Sale price (in Dollars per share) | $ / shares					$ 400
Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)						143,750
Stonepeak/Evolve Warrants - series B
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares							$ 400
Number of Warrants Exercisable (in shares)							50,000
Total recurring fair value measurements | $				$ 12,800,000
Stonepeak/Evolve Warrants - series C
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares							$ 600
Number of Warrants Exercisable (in shares)							12,500
Total recurring fair value measurements | $				5,600,000
Stonepeak/Evolve Warrants - series D
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares							$ 800
Number of Warrants Exercisable (in shares)							12,500
Total recurring fair value measurements | $				4,800,000
Stonepeak/Evolve Warrants - series E
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares							$ 1,200
Number of Warrants Exercisable (in shares)							12,500
Total recurring fair value measurements | $				3,800,000
Stonepeak/Evolve Warrants - series F
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares							$ 1,600
Number of Warrants Exercisable (in shares)							12,500
Total recurring fair value measurements | $				$ 3,200,000
Stonepeak Warrants | Securities Purchase Agreement
Stockholders' Equity [Line Items]
Percent of warrants issued				90%
Evolve Warrants | Securities Purchase Agreement
Stockholders' Equity [Line Items]
Percent of warrants issued				10%
Underwriting Agreement
Stockholders' Equity [Line Items]
Amount of purchase | $	$ 9,600,000
Per unit price (in Dollars per share) | $ / shares		$ 2
Share price adjustment | $ / shares		1.9999
Underwriting Agreement | Underwriter Warrants
Stockholders' Equity [Line Items]
Exercise price (in Dollars per share) | $ / shares		$ 2
Warrants outstanding, term		5 years
Number of securities called by warrants (in shares)		480,000
Number of Warrants Exercisable (in shares)		240,000
Underwriting Agreement | Common Stock
Stockholders' Equity [Line Items]
Underwriter agent fee percentage	7%
Sale of units (in Shares)		3,035,000
Underwriting Agreement | Warrants | Pre-Funded Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)		1,765,000
Exercise price (in Dollars per share) | $ / shares		$ 0.0001
Underwriting Agreement | Warrants | Series A Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)		4,800,000
Exercise price (in Dollars per share) | $ / shares		$ 2
Warrants outstanding, term		5 years
Class of warrant or right, number of securities called by each warrant		1
Underwriting Agreement | Warrants | Series B Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)		4,800,000
Exercise price (in Dollars per share) | $ / shares		$ 2
Warrants outstanding, term		9 months
Class of warrant or right, number of securities called by each warrant		1
Underwriting Agreement | Warrants | Series C Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares)		4,800,000
Exercise price (in Dollars per share) | $ / shares		$ 2
Warrants outstanding, term		5 years
Class of warrant or right, number of securities called by each warrant		1
IPO | Newborn
Stockholders' Equity [Line Items]
Class of warrant or right, number of securities called by each warrant						1
Number of warrants per unit (in Shares)						1
Private Placement | Newborn
Stockholders' Equity [Line Items]
Number of warrants per unit (in Shares)						1
Private Placement | Warrants
Stockholders' Equity [Line Items]
Aggregate share purchase (in Shares)						6,813

Stockholders_ Equity (Deficit_3

Stockholders’ Equity (Deficit) - Schedule of common stock issuable upon exercise of warrants outstanding (Details)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	15,334,125
Number of Warrants Exercised (in shares)	875,000
Number of Warrants Exercisable (in shares)	14,409,125
Public Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	71,875
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	71,875
Exercise price (in Dollars per share) | $ / shares	$ 460
Private Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	3,406
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	3,406
Exercise price (in Dollars per share) | $ / shares	$ 460
PIPE Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	33,844
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	33,844
Exercise price (in Dollars per share) | $ / shares	$ 460
Stonepeak/Evolve Warrants - series B
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	50,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	50,000
Exercise price (in Dollars per share) | $ / shares	$ 400
Stonepeak/Evolve Warrants - series C
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	25,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	12,500
Exercise price (in Dollars per share) | $ / shares	$ 600
Stonepeak/Evolve Warrants - series D
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	25,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	12,500
Exercise price (in Dollars per share) | $ / shares	$ 800
Stonepeak/Evolve Warrants - series E
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	25,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	12,500
Exercise price (in Dollars per share) | $ / shares	$ 1,200
Stonepeak/Evolve Warrants - series F
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	25,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	12,500
Exercise price (in Dollars per share) | $ / shares	$ 1,600
2022 July Institutional/Accredited Investor Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	100,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	100,000
Exercise price (in Dollars per share) | $ / shares	$ 150
2024 February Institutional/Accredited Investor Pre-Funded Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	575,000
Number of Warrants Exercised (in shares)	575,000
Number of Warrants Exercisable (in shares)	0
Exercise price (in Dollars per share) | $ / shares	$ 0.0001
2024 February Institutional/Accredited Investor Warrants - series A
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	4,800,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	4,800,000
Exercise price (in Dollars per share) | $ / shares	$ 2
2024 February Institutional/Accredited Investor Warrants - series B
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	4,800,000
Number of Warrants Exercised (in shares)	300,000
Number of Warrants Exercisable (in shares)	4,500,000
Exercise price (in Dollars per share) | $ / shares	$ 2
2024 February Institutional/Accredited Investor Warrants - series C
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	4,800,000
Number of Warrants Exercised (in shares)	0
Number of Warrants Exercisable (in shares)	4,800,000
Exercise price (in Dollars per share) | $ / shares	$ 2

Stockholders_ Equity (Deficit_4

Stockholders’ Equity (Deficit) - Securities Purchase Agreement, Pre-Funded Warrants and Warrants (Details) - $ / shares	Feb. 19, 2020	Jun. 30, 2024	Dec. 31, 2023
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Common stock par value (in Dollars per share)		$ 0.0001	$ 0.0001
Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Sale of units (in Shares)	143,750

Stock Option Plan - Narrative (

Stock Option Plan - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2021	Aug. 06, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based option modified (in Shares)						41,000
Increase decrease exercise price (in Dollars per share)						$ 24
Incremental compensation cost (in Dollars)						$ 246,000
Weighted average remaining recognition period				9 months 25 days
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional compensation expense		$ 0	$ 11,618	$ 169	$ 24,250
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to nonvested restricted stock		$ 1,851		$ 1,851
Weighted average remaining recognition period				1 month 2 days
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)	100,000
Aggregate of common shares (in Shares)		182,500		182,500
Option contractual life				10 years
Weighted average grant date fair value of options granted during period (in Dollars per share)				$ 0
2020 Plan | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock available for future (in Shares)							59,727
2020 Plan | Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option vesting period				4 years
2010 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value of options granted during period (in Dollars per share)				$ 0

Stock Option Plan - Schedule of

Stock Option Plan - Schedule of stock-based compensation expense for stock options (Details) - Selling, general and administrative - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 513,026	$ 1,103,406	$ 1,390,808	$ 2,069,227
Options
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	362,748	667,923	1,040,231	1,350,871
Restricted stock
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	119,052	389,646	287,956	985,807
Stock options - modified options
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	0	11,618	169	24,250
Profit interest units
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 31,226	$ 34,219	$ 62,452	$ (291,701)

Stock Option Plan - Schedule _2

Stock Option Plan - Schedule of stock option activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
2010 Plan
Shares
Beginning balance (in Shares)	19,115
Granted, (in Shares)	0
Exercised (in Shares)	0
Forfeited (in Shares)	(11)
Expired/Cancelled (in Shares)	(53)
Ending balance (in Shares)	19,051	19,115
Options exercisable (in Shares)	19,044
Options vested (in Shares)	19,044
Weighted- Average Exercise Price per Share($)
Beginning balance (in Dollars per share)	$ 102.75
Granted (in Dollars per share)	0
Exercised (in Dollars per share)	0
Forfeited (in Dollars per share)	344.89
Expired/Cancelled (in Dollars per share)	54.61
Ending balance (in Dollars per share)	102.85	$ 102.75
Options exercisable (in Dollars per share)	102.76
Options vested (in Dollars per share)	$ 102.76
Weighted- Average Remaining Contractual Term (Years)
Outstanding, weighted-average remaining contractual term	3 years 3 days	3 years 6 months 10 days
Options exercisable, weighted average remaining contractual term	3 years
Options vested, weighted average remaining contractual term	3 years
Aggregate Intrinsic Value($)
Outstanding	$ 0	$ 0
Exercisable	0
Vested	$ 0
2020 Plan
Shares
Beginning balance (in Shares)	57,892
Granted, (in Shares)	0
Exercised (in Shares)	0
Forfeited (in Shares)	(4,087)
Expired/Cancelled (in Shares)	(4,618)
Ending balance (in Shares)	49,187	57,892
Options exercisable (in Shares)	29,581
Options vested (in Shares)	29,581
Weighted- Average Exercise Price per Share($)
Beginning balance (in Dollars per share)	$ 338.67
Granted (in Dollars per share)	0
Exercised (in Dollars per share)	0
Forfeited (in Dollars per share)	123.89
Expired/Cancelled (in Dollars per share)	109.54
Ending balance (in Dollars per share)	377.73	$ 338.67
Options exercisable (in Dollars per share)	501.82
Options vested (in Dollars per share)	$ 501.82
Weighted- Average Remaining Contractual Term (Years)
Outstanding, weighted-average remaining contractual term	7 years 2 months 19 days	7 years 10 months 28 days
Options exercisable, weighted average remaining contractual term	6 years 10 months 20 days
Options vested, weighted average remaining contractual term	6 years 10 months 20 days
Aggregate Intrinsic Value($)
Outstanding	$ 0	$ 0
Exercisable	0
Vested	$ 0

Stock Option Plan - Schedule _3

Stock Option Plan - Schedule of other share based compensation information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Amount received from option exercised	$ 0	$ 0
Total unrecognized options compensation costs	$ 1,810,081
Weighted average remaining recognition period	9 months 25 days

Stock Option Plan - Schedule _4

Stock Option Plan - Schedule of nonvested restricted stock units (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Shares
Beginning balance (in Shares) | shares	10,307
Granted (in Shares) | shares	0
Vested/Release (in Shares) | shares	(7,334)
Cancelled/Forfeited (in Shares) | shares	(2,933)
Ending balance (in Shares) | shares	40
Weighted- Average Grant Date Fair Value($)
Beginning balance (in Dollars per share) | $ / shares	$ 98.03
Granted (in Dollars per share) | $ / shares	0
Vested/Release (in Dollars per share) | $ / shares	261.14
Cancelled/Forfeited (in Dollars per share) | $ / shares	280.13
Ending balance (in Dollars per share) | $ / shares	$ 1,587.46

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 0	$ 0	$ 0	$ 0
Effective tax rate	0%	0%	0%	0%

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net loss attributable to Nuvve Holding Corp. common stockholders, basic	$ (4,176,717)	$ (8,224,707)	$ (11,127,626)	$ (16,121,858)
Net loss attributable to Nuvve Holding Corp. common stockholders, diluted	$ (4,176,717)	$ (8,224,707)	$ (11,127,626)	$ (16,121,858)
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic (in Shares)	6,230,284	693,353	5,172,358	653,245
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, diluted (in Shares)	6,230,284	693,353	5,172,358	653,245
Net Loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)	$ (0.67)	$ (11.86)	$ (2.15)	$ (24.68)
Net Loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)	$ (0.67)	$ (11.86)	$ (2.15)	$ (24.68)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Attributable to Nuvve common stockholders (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	14,662,149	556,789	14,652,926	555,533
Stock options issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	72,847	63,074	68,761	62,783
Nonvested restricted stock issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	5,176	9,590	40	8,625
Public warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	71,875	71,875	71,875	71,875
Private warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	3,406	3,406	3,406	3,406
PIPE warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	33,844	33,844	33,844	33,844
Stonepeak and Evolve warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	150,000	150,000	150,000	150,000
Stonepeak and Evolve options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	125,000	125,000	125,000	125,000
2022 July Institutional/Accredited Investor Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	100,000	100,000	100,000	100,000
2024 February Institutional/Accredited Investor Warrants - series A
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	4,800,000	0	4,800,000	0
2024 February Institutional/Accredited Investor Warrants - series B
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	4,500,000	0	4,500,000	0
2024 February Institutional/Accredited Investor Warrants - series C
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	4,800,000	0	4,800,000	0

Related Parties (Details)

Related Parties (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Related Party Transaction [Line Items]
Revenue	$ 802,180	$ 2,120,127	$ 1,581,936	$ 3,974,913
Accounts receivable, net	516,193		516,193		$ 1,724,899
Related Party
Related Party Transaction [Line Items]
Revenue	63,517	$ 0	139,176	$ 65,670
Accounts receivable, net	$ 0		$ 0		$ 0

Leases - Lease cost (Details)

Leases - Lease cost (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Lessee, Lease, Description [Line Items]
Right-of-use operating lease assets	$ 4,593,229		$ 4,593,229		$ 4,839,526
Finance lease assets	9,925		9,925		13,154
Total lease assets	$ 4,603,154		$ 4,603,154		4,852,680
Finance lease, right-of-use asset, statement of financial position [extensible list]	Property and equipment, net		Property and equipment, net
Operating lease liabilities - current	$ 848,497		$ 848,497		856,250
Operating lease liabilities - noncurrent	4,413,069		4,413,069		4,646,383
Finance lease liabilities - current	7,170		7,170		7,391
Finance lease liabilities - noncurrent	4,621		4,621		7,764
Total lease obligations	$ 5,273,357		$ 5,273,357		$ 5,517,788
Finance lease, liability, current, statement of financial position, extensible list	Other liabilities		Other liabilities
Finance lease, liability, noncurrent, statement of financial position, extensible list	Other long-term liabilities		Other long-term liabilities
Total lease expense	$ 230,377	$ 230,529	$ 460,473	$ 461,079
Selling, general and administrative
Lessee, Lease, Description [Line Items]
Operating lease expense	228,633	228,633	457,248	457,267
Amortization of finance lease assets	1,423	1,432	2,547	2,855
Interest income, net
Lessee, Lease, Description [Line Items]
Interest income, net	$ 321	$ 464	$ 678	$ 957

Leases - Schedule of operating

Leases - Schedule of operating lease liability maturity (Details)	Jun. 30, 2024 USD ($)
Operating Lease
2024	$ 440,551
2025	893,046
2026	921,273
2027	946,683
2028	937,727
Thereafter	2,860,827
Total lease payments	7,000,107
Less: interest	(1,738,541)
Total lease obligations	5,261,566
Finance Lease
2024	3,585
2025	7,170
2026	1,793
2027	0
2028	0
Thereafter	0
Total lease payments	12,548
Less: interest	(757)
Total lease obligations	$ 11,791

Leases - Lease term, discount r

Leases - Lease term, discount rate, and other information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Weighted-average remaining lease terms (in years):
Operating lease	7 years 4 months 24 days		7 years 9 months 18 days
Finance lease	1 year 9 months 18 days		2 years 6 months
Weighted-average discount rate:
Operating lease	7.80%		7.80%
Finance lease	7.80%		7.80%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows - operating leases	$ 252,997	$ 229,044
Operating cash flows - finance leases	3,526	4,686
Financing cash flows - finance leases	5,477	4,480
Leased assets obtained in exchange for new finance lease liabilities	9,925	15,918
Leased assets obtained in exchange for new operating lease liabilities	$ 0	$ 0

Leases - Sublease (Details)

Leases - Sublease (Details)	1 Months Ended	3 Months Ended		6 Months Ended
	Apr. 30, 2022 USD ($) ft²	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Lessee, Lease, Description [Line Items]
Net area subleased | ft²	4,811
Minimum
Lessee, Lease, Description [Line Items]
Sublease term	6 months
Sublease monthly rental income	$ 2,250
Maximum
Lessee, Lease, Description [Line Items]
Sublease term	12 months
Sublease monthly rental income	$ 14,500
Other, net
Lessee, Lease, Description [Line Items]
Sublease lease income		$ 112,578	$ 101,915	$ 213,379	$ 231,685

Leases - Lessor (Details)

Leases - Lessor (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Feb. 28, 2022
Lessee, Lease, Description [Line Items]
Investment in leases	$ 106,916		$ 106,916		$ 112,255
Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]			Total revenue
Master Services Agreement
Lessee, Lease, Description [Line Items]
Lease term (in years)						10 years
Lease income	1,138	$ 24,027	$ 2,276	$ 24,027
Interest income	4,864	3,835	8,979	6,430
Total lease income	$ 6,002	$ 27,862	$ 11,255	$ 30,457

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details)			1 Months Ended	2 Months Ended	6 Months Ended	12 Months Ended
	Feb. 02, 2024 USD ($)	Nov. 01, 2023 USD ($) bus	Nov. 30, 2017 USD ($)	Nov. 30, 2021 USD ($) bus	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jul. 20, 2021 USD ($)	Sep. 01, 2016 USD ($)
Other Commitments [Line Items]
Installment amount					$ 42,714		$ 233,333		$ 400,000
Property expire					20 years
Royalty expense, aggregate amount under agreement					$ 700,000
Royalty expense					0	$ 0
Acquisition costs, amortization period			15 years
Investment					270,000
Purchase obligation								$ 13,200,000
Loss contingency, accrual current	$ 460,000
Loss Contingency, Accrual Payment Period	15 days
Loss Contingency, accrual noncurrent	$ 2,400,000
Loss contingency, accrual payments percentage	50%
Loss contingency minimum payment upon shipment, period	12 months
Loss contingency remaining payment upon shipment, period	24 months
School Bus Storage Litigation
Other Commitments [Line Items]
Number of school buses purchased | bus				5
Number of school buses in dispute | bus				4
Storage fees in dispute				$ 450,000
Number of buses granted release by the court | bus		4
Number of buses with MSO's | bus		5
Injunction bond		$ 550,000
IP Acquisition Agreement
Other Commitments [Line Items]
Asset acquisition, upfront payment			$ 500,000
Asset acquisition, equity consideration transferred			1,491,556
Asset acquisition, consideration transferred			1,991,556
Royalties payments			$ 7,500,000
Royalty agreement, minimum access period to Company's GIVe platform			6 months
Related Party
Other Commitments [Line Items]
Related party debt outstanding					$ 213,571

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of milestone event (Details)	6 Months Ended
	Jun. 30, 2024 USD ($)
Other Commitments [Line Items]
Milestone payment amount	$ 7,500,000
10000
Other Commitments [Line Items]
Milestone payment amount	500,000
20000
Other Commitments [Line Items]
Milestone payment amount	750,000
40000
Other Commitments [Line Items]
Milestone payment amount	750,000
60000
Other Commitments [Line Items]
Milestone payment amount	750,000
80000
Other Commitments [Line Items]
Milestone payment amount	750,000
100000
Other Commitments [Line Items]
Milestone payment amount	1,000,000
200000
Other Commitments [Line Items]
Milestone payment amount	1,000,000
250000
Other Commitments [Line Items]
Milestone payment amount	$ 2,000,000

Non-Controlling Interest - Narr

Non-Controlling Interest - Narrative (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) vesting_installment $ / shares shares	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares) | shares	1,000,000		1,000,000		1,000,000
Temporary equity, par value (in Dollars per share) | $ / shares	$ 0		$ 0		$ 0
Temporary equity, shares issued (in Shares) | shares	3,138		3,138		3,138
Temporary equity, shares outstanding (in Shares) | shares	3,138		3,138		3,138
Decrease to redeemable noncontrolling interest			$ 497,606
Redeemable noncontrolling interest, equity, carrying amount	$ 2,640,394		$ 2,640,394
Accretion period (in years)			7 years
Weighted average remaining recognition period			9 months 25 days
Selling, general and administrative
Noncontrolling Interest [Line Items]
Stock-based compensation	513,026	$ 1,103,406	$ 1,390,808	$ 2,069,227
Class D Incentive Units
Noncontrolling Interest [Line Items]
Vesting percentage			80%
Number of vesting installments | vesting_installment			4
Percentage of incentive units to be vested			20%
Total unrecognized compensation cost related to nonvested restricted stock	220,930		$ 220,930
Weighted average remaining recognition period			1 year 6 months
Class D Incentive Units | Selling, general and administrative
Noncontrolling Interest [Line Items]
Stock-based compensation	31,226	$ 34,219	$ 62,452	$ 62,451
Class D Incentive Units | Share-Based Payment Arrangement, All Tranches
Noncontrolling Interest [Line Items]
Vesting percentage			80%
Class D Incentive Units | Share Based Arrangement Tranche Four
Noncontrolling Interest [Line Items]
Vesting percentage			25%
Class D Incentive Units | Share-Based Payment Arrangement, Tranche One
Noncontrolling Interest [Line Items]
Vesting percentage			25%
Class D Incentive Units | Share-Based Payment Arrangement, Tranche Three
Noncontrolling Interest [Line Items]
Vesting percentage			25%
Class D Incentive Units | Share-Based Payment Arrangement, Tranche Two
Noncontrolling Interest [Line Items]
Vesting percentage			25%
Redeemable non controlling interests
Noncontrolling Interest [Line Items]
Redeemable noncontrolling interest, equity, carrying amount	$ 4,516,561		$ 4,516,561		$ 4,193,629	$ 3,547,765
Preferred share Accretion adjustment			$ 322,932		$ 645,864
Series B Preferred Stock | Levo Mobility LLC
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares) | shares	1,000,000		1,000,000
Temporary equity, dividend rate, percentage			8%
Temporary equity, par value (in Dollars per share) | $ / shares	$ 1,000		$ 1,000
Temporary equity, accretion of dividends			$ 763,709
Temporary equity, shares issued (in Shares) | shares	3,138		3,138
Temporary equity, shares outstanding (in Shares) | shares	3,138		3,138
Redeemable noncontrolling interest, equity, fair value	$ 3,138,000		$ 3,138,000

Non-Controlling Interest - Seri

Non-Controlling Interest - Series B Preferred Stock (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares)	1,000,000	1,000,000
Temporary equity, shares outstanding (in Shares)	3,138	3,138
Temporary equity, shares issued (in Shares)	3,138	3,138
Temporary equity, par value (in Dollars per share)	$ 0	$ 0
Temporary equity, liquidation preference	$ 3,901,709	$ 3,750,201
Series B Preferred Stock | Levo Mobility LLC
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares)	1,000,000
Temporary equity, shares outstanding (in Shares)	3,138
Temporary equity, shares issued (in Shares)	3,138
Temporary equity, par value (in Dollars per share)	$ 1,000
Redeemable noncontrolling interest, equity, fair value	$ 3,138,000
Temporary equity, accretion of dividends	763,709
Temporary equity, liquidation preference	$ 3,901,709

Non-Controlling Interest - Non-

Non-Controlling Interest - Non-controlling interests presented as a separate component of stockholders’ equity (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning balance		$ (4,894,101)			$ (4,894,101)
Net income (loss) attributable to non-controlling interests	$ (10,268)		$ 8,466		(24,566)	$ 14,754
Less: dividends paid to non-controlling interests	76,504	75,004	$ 70,678	$ 69,292
Non-controlling interests	(5,393,107)				(5,393,107)		$ (4,894,101)
Levo Mobility LLC
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning balance		$ (4,894,101)		$ (3,950,186)	(4,894,101)	$ (3,950,186)	(3,950,186)
Net income (loss) attributable to non-controlling interests					(24,566)		(12,456)
Less: dividends paid to non-controlling interests					151,508		285,595
Less: Preferred share accretion adjustment					322,932		645,864
Non-controlling interests	$ (5,393,107)				$ (5,393,107)		$ (4,894,101)

Non-Controlling Interest - Cond

Non-Controlling Interest - Condensed consolidated statements of operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Levo Mobility LLC
Noncontrolling Interest [Line Items]
Net income (loss) attributable to non-controlling interests	$ (10,268)	$ 8,466	$ (24,566)	$ 14,754

Non-Controlling Interest - Rede

Non-Controlling Interest - Redeemable noncontrolling interest reconciliation (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Increase (Decrease) in Temporary Equity [Roll Forward]
Ending balance	$ 2,640,394
Redeemable non controlling interests
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	4,193,629	$ 3,547,765
Preferred share Accretion adjustment	322,932	645,864
Ending balance	$ 4,516,561	$ 4,193,629

Noncontrolling Interest - Sched

Noncontrolling Interest - Schedule of Monte Carlo Simulation model to estimate the fair value of class D incentive Units (Details) - Class D Incentive Units	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest [Line Items]
Expected life of Class D Incentive Units (in years)	5 years 6 months
Risk-free interest rate	3.02%
Volatility	69.50%

Noncontrolling Interest - Sch_2

Noncontrolling Interest - Schedule of nonvested Class D Incentive Units (Details) - Class D Incentive Units	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Shares
Beginning balance (in Shares) | shares	50,000
Granted (in Shares) | shares	0
Vested (in Shares) | shares	0
Cancelled (in Shares) | shares	0
Ending balance (in Shares) | shares	50,000
Weighted- Average Grant Date Fair Value($)
Beginning balance (in Dollars per share) | $ / shares	$ 12.49
Granted (in Dollars per share) | $ / shares	0
Vested (in Dollars per share) | $ / shares	0
Cancelled (in Dollars per share) | $ / shares	0
Ending balance (in Dollars per share) | $ / shares	$ 12.49

Subsequent Events - Schedule of

Subsequent Events - Schedule of Short-Term Debt (Details) - Term Loan - Subordinated Business Loan - Subsequent Event $ in Thousands	Aug. 09, 2024 USD ($)
Subsequent Event [Line Items]
Principal Amount Borrowed	$ 1,000
Carrying Value	$ 1,000
Weighted Weekly Average Interest Rate	2.96%

Subsequent Events (Details)

Subsequent Events (Details) - Term Loan - Subordinated Business Loan - USD ($)		7 Months Ended
	Aug. 09, 2024	Mar. 06, 2025
Forecast
Subsequent Event [Line Items]
Debt instrument, interest to be paid		$ 522,501
Subsequent Event
Subsequent Event [Line Items]
Debt instrument, term	210 days
Debt instrument, weekly principal and interest payment	$ 50,750